| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC7A9 CNNM2 SLC13A1 MLC1 KCNJ8 TRPC1 SCN4B SLC9B2 SLC10A6 SLC7A5 SLC7A7 SLC7A5P1 ATP2B1 AQP7 SLC45A4 ATP5F1B | 2.01e-08 | 1180 | 51 | 16 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | SLC7A9 CNNM2 SLC13A1 MLC1 KCNJ8 TRPC1 SCN4B SLC9B2 SLC10A6 SLC7A5 SLC7A7 SLC7A5P1 ATP2B1 AQP7 SLC45A4 ATP5F1B | 6.89e-08 | 1289 | 51 | 16 | GO:0005215 |
| GeneOntologyMolecularFunction | peptide antigen binding | 1.56e-07 | 49 | 51 | 5 | GO:0042605 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CNNM2 SLC13A1 KCNJ8 TRPC1 SCN4B SLC9B2 SLC10A6 ATP2B1 AQP7 SLC45A4 ATP5F1B | 2.61e-06 | 758 | 51 | 11 | GO:0015318 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC7A9 SLC13A1 KCNJ8 SLC9B2 SLC10A6 SLC7A5 ATP2B1 SLC45A4 ATP5F1B | 2.93e-06 | 477 | 51 | 9 | GO:0022804 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CNNM2 SLC13A1 KCNJ8 TRPC1 SCN4B SLC9B2 SLC10A6 ATP2B1 SLC45A4 ATP5F1B | 3.47e-06 | 627 | 51 | 10 | GO:0022890 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CNNM2 SLC13A1 MLC1 KCNJ8 TRPC1 SCN4B SLC9B2 SLC10A6 ATP2B1 SLC45A4 ATP5F1B | 4.02e-06 | 793 | 51 | 11 | GO:0015075 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CNNM2 SLC13A1 KCNJ8 TRPC1 SCN4B SLC9B2 SLC10A6 ATP2B1 SLC45A4 ATP5F1B | 5.76e-06 | 664 | 51 | 10 | GO:0008324 |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 1.08e-05 | 301 | 51 | 7 | GO:0022853 | |
| GeneOntologyMolecularFunction | peptide binding | 1.54e-05 | 318 | 51 | 7 | GO:0042277 | |
| GeneOntologyMolecularFunction | hedgehog receptor activity | 1.92e-05 | 3 | 51 | 2 | GO:0008158 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 2.15e-05 | 465 | 51 | 8 | GO:0046873 | |
| GeneOntologyMolecularFunction | smoothened binding | 3.82e-05 | 4 | 51 | 2 | GO:0005119 | |
| GeneOntologyMolecularFunction | hedgehog family protein binding | 3.82e-05 | 4 | 51 | 2 | GO:0097108 | |
| GeneOntologyMolecularFunction | MHC class I protein binding | 7.39e-05 | 32 | 51 | 3 | GO:0042288 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 1.04e-04 | 296 | 51 | 6 | GO:0015291 | |
| GeneOntologyMolecularFunction | antigen binding | 1.22e-04 | 190 | 51 | 5 | GO:0003823 | |
| GeneOntologyMolecularFunction | TAP complex binding | 2.28e-04 | 9 | 51 | 2 | GO:0062061 | |
| GeneOntologyMolecularFunction | CD8 receptor binding | 2.28e-04 | 9 | 51 | 2 | GO:0042610 | |
| GeneOntologyMolecularFunction | PDZ domain binding | 2.74e-04 | 123 | 51 | 4 | GO:0030165 | |
| GeneOntologyMolecularFunction | TAP1 binding | 2.84e-04 | 10 | 51 | 2 | GO:0046978 | |
| GeneOntologyMolecularFunction | TAP2 binding | 2.84e-04 | 10 | 51 | 2 | GO:0046979 | |
| GeneOntologyMolecularFunction | TAP binding | 2.84e-04 | 10 | 51 | 2 | GO:0046977 | |
| GeneOntologyMolecularFunction | beta-2-microglobulin binding | 4.15e-04 | 12 | 51 | 2 | GO:0030881 | |
| GeneOntologyMolecularFunction | MHC protein binding | 4.39e-04 | 58 | 51 | 3 | GO:0042287 | |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 5.34e-04 | 62 | 51 | 3 | GO:0019829 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 6.13e-04 | 65 | 51 | 3 | GO:0004714 | |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 7.94e-04 | 71 | 51 | 3 | GO:0015179 | |
| GeneOntologyMolecularFunction | natural killer cell lectin-like receptor binding | 8.49e-04 | 17 | 51 | 2 | GO:0046703 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 9.48e-04 | 171 | 51 | 4 | GO:0015081 | |
| GeneOntologyMolecularFunction | ephrin receptor activity | 1.06e-03 | 19 | 51 | 2 | GO:0005003 | |
| GeneOntologyMolecularFunction | T cell receptor binding | 1.18e-03 | 20 | 51 | 2 | GO:0042608 | |
| GeneOntologyMolecularFunction | basic amino acid transmembrane transporter activity | 1.18e-03 | 20 | 51 | 2 | GO:0015174 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 1.34e-03 | 85 | 51 | 3 | GO:0019199 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 1.92e-03 | 207 | 51 | 4 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 1.95e-03 | 208 | 51 | 4 | GO:0005342 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | EPHB4 ERBB2 HLA-DQA1 EPHA2 PTCH2 SUCNR1 PTCH1 ITGB2 UNC5D OR8B8 | 1.96e-03 | 1353 | 51 | 10 | GO:0004888 |
| GeneOntologyMolecularFunction | channel activity | 2.12e-03 | 525 | 51 | 6 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 2.14e-03 | 526 | 51 | 6 | GO:0022803 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 2.45e-03 | 105 | 51 | 3 | GO:0015171 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 2.72e-03 | 109 | 51 | 3 | GO:0042626 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 3.49e-03 | 119 | 51 | 3 | GO:0015294 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 4.07e-03 | 599 | 51 | 6 | GO:0050839 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 4.92e-03 | 41 | 51 | 2 | GO:0015175 | |
| GeneOntologyMolecularFunction | 14-3-3 protein binding | 5.16e-03 | 42 | 51 | 2 | GO:0071889 | |
| GeneOntologyMolecularFunction | carbohydrate transmembrane transporter activity | 5.16e-03 | 42 | 51 | 2 | GO:0015144 | |
| GeneOntologyMolecularFunction | antiporter activity | 5.28e-03 | 138 | 51 | 3 | GO:0015297 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 6.05e-03 | 145 | 51 | 3 | GO:0004713 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 6.19e-03 | 459 | 51 | 5 | GO:0005216 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 6.61e-03 | 293 | 51 | 4 | GO:0008514 | |
| GeneOntologyMolecularFunction | symporter activity | 6.65e-03 | 150 | 51 | 3 | GO:0015293 | |
| GeneOntologyMolecularFunction | protein-folding chaperone binding | 8.07e-03 | 161 | 51 | 3 | GO:0051087 | |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 9.66e-03 | 172 | 51 | 3 | GO:0044325 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 1.06e-02 | 178 | 51 | 3 | GO:0015399 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 1.06e-02 | 61 | 51 | 2 | GO:1901682 | |
| GeneOntologyMolecularFunction | cell-cell adhesion mediator activity | 1.06e-02 | 61 | 51 | 2 | GO:0098632 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 1.13e-02 | 343 | 51 | 4 | GO:0005261 | |
| GeneOntologyMolecularFunction | proton transmembrane transporter activity | 1.23e-02 | 188 | 51 | 3 | GO:0015078 | |
| GeneOntologyMolecularFunction | metalloexopeptidase activity | 1.38e-02 | 70 | 51 | 2 | GO:0008235 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 1.38e-02 | 70 | 51 | 2 | GO:1901618 | |
| GeneOntologyMolecularFunction | cell adhesion mediator activity | 1.62e-02 | 76 | 51 | 2 | GO:0098631 | |
| GeneOntologyBiologicalProcess | L-amino acid transport | 2.66e-07 | 108 | 51 | 6 | GO:0015807 | |
| GeneOntologyBiologicalProcess | L-alpha-amino acid transmembrane transport | 2.40e-06 | 87 | 51 | 5 | GO:1902475 | |
| GeneOntologyBiologicalProcess | positive regulation of immune system process | EPHB4 HLA-B CD99 HLA-DQA1 KCNJ8 SLC9B2 HLA-F CD47 SLC7A5 DLK1 APP IL4I1 ITGB2 | 7.14e-06 | 1242 | 51 | 13 | GO:0002684 |
| GeneOntologyBiologicalProcess | amino acid transport | 8.36e-06 | 195 | 51 | 6 | GO:0006865 | |
| GeneOntologyBiologicalProcess | amino acid transmembrane transport | 1.16e-05 | 120 | 51 | 5 | GO:0003333 | |
| GeneOntologyBiologicalProcess | neutral amino acid transport | 1.46e-05 | 60 | 51 | 4 | GO:0015804 | |
| GeneOntologyBiologicalProcess | basic amino acid transport | 2.12e-05 | 22 | 51 | 3 | GO:0015802 | |
| GeneOntologyBiologicalProcess | neuromuscular junction development | 2.40e-05 | 68 | 51 | 4 | GO:0007528 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure by circulatory renin-angiotensin | 2.44e-05 | 23 | 51 | 3 | GO:0001991 | |
| GeneOntologyBiologicalProcess | multicellular organism growth | 3.33e-05 | 249 | 51 | 6 | GO:0035264 | |
| GeneOntologyBiologicalProcess | organic anion transport | 3.54e-05 | 515 | 51 | 8 | GO:0015711 | |
| GeneOntologyBiologicalProcess | regulation of cardiac conduction | 4.97e-05 | 29 | 51 | 3 | GO:1903779 | |
| GeneOntologyBiologicalProcess | carboxylic acid transmembrane transport | 5.08e-05 | 163 | 51 | 5 | GO:1905039 | |
| GeneOntologyBiologicalProcess | positive regulation of transport | ACE2 MLC1 TRPC1 SCN4B HLA-F CD47 SLC7A5 APP PTCH1 ITGB2 ATP2B1 | 5.36e-05 | 1081 | 51 | 11 | GO:0051050 |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | 5.70e-05 | 167 | 51 | 5 | GO:1903825 | |
| GeneOntologyBiologicalProcess | cytokine production | ACE2 HLA-B EPHA2 KCNJ8 HLA-F CD47 SLC7A5 DLK1 SUCNR1 APP ATP2B1 | 5.83e-05 | 1091 | 51 | 11 | GO:0001816 |
| GeneOntologyBiologicalProcess | endothelin production | 5.97e-05 | 5 | 51 | 2 | GO:1990775 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | 6.34e-05 | 410 | 51 | 7 | GO:0046942 | |
| GeneOntologyBiologicalProcess | organic acid transport | 6.54e-05 | 412 | 51 | 7 | GO:0015849 | |
| GeneOntologyBiologicalProcess | circulatory system process | 6.87e-05 | 733 | 51 | 9 | GO:0003013 | |
| GeneOntologyBiologicalProcess | epidermal cell fate specification | 8.93e-05 | 6 | 51 | 2 | GO:0009957 | |
| GeneOntologyBiologicalProcess | tryptophan transport | 8.93e-05 | 6 | 51 | 2 | GO:0015827 | |
| GeneOntologyBiologicalProcess | regulation of nitric oxide biosynthetic process | 9.69e-05 | 97 | 51 | 4 | GO:0045428 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure by renin-angiotensin | 1.04e-04 | 37 | 51 | 3 | GO:0003081 | |
| GeneOntologyBiologicalProcess | regulation of nitric oxide metabolic process | 1.09e-04 | 100 | 51 | 4 | GO:0080164 | |
| GeneOntologyBiologicalProcess | cardiac conduction | 1.09e-04 | 100 | 51 | 4 | GO:0061337 | |
| GeneOntologyBiologicalProcess | leukocyte activation | EPHB4 ERBB2 CD99 HLA-DQA1 KCNJ8 HLA-F CD47 SUCNR1 APP IL4I1 ITGB2 | 1.23e-04 | 1186 | 51 | 11 | GO:0045321 |
| GeneOntologyBiologicalProcess | positive regulation of gap junction assembly | 1.25e-04 | 7 | 51 | 2 | GO:1903598 | |
| GeneOntologyBiologicalProcess | peptide hormone processing | 1.42e-04 | 41 | 51 | 3 | GO:0016486 | |
| GeneOntologyBiologicalProcess | regulation of blood circulation | 1.47e-04 | 326 | 51 | 6 | GO:1903522 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent | 1.66e-04 | 8 | 51 | 2 | GO:0002485 | |
| GeneOntologyBiologicalProcess | nitric oxide biosynthetic process | 1.69e-04 | 112 | 51 | 4 | GO:0006809 | |
| GeneOntologyBiologicalProcess | blood circulation | 1.75e-04 | 648 | 51 | 8 | GO:0008015 | |
| GeneOntologyBiologicalProcess | signaling receptor ligand precursor processing | 2.01e-04 | 46 | 51 | 3 | GO:0140448 | |
| GeneOntologyBiologicalProcess | angiotensin maturation | 2.13e-04 | 9 | 51 | 2 | GO:0002003 | |
| GeneOntologyBiologicalProcess | nitric oxide metabolic process | 2.28e-04 | 121 | 51 | 4 | GO:0046209 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen | 2.28e-04 | 48 | 51 | 3 | GO:0002478 | |
| GeneOntologyBiologicalProcess | reactive nitrogen species metabolic process | 2.42e-04 | 123 | 51 | 4 | GO:2001057 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | EPHB4 KIRREL3 ERBB2 CD99 HLA-DQA1 CD47 IL4I1 EPCAM ITGB2 UNC5D | 2.61e-04 | 1077 | 51 | 10 | GO:0098609 |
| GeneOntologyBiologicalProcess | regulation of gap junction assembly | 2.66e-04 | 10 | 51 | 2 | GO:1903596 | |
| GeneOntologyBiologicalProcess | L-leucine transport | 2.66e-04 | 10 | 51 | 2 | GO:0015820 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure by hormone | 2.73e-04 | 51 | 51 | 3 | GO:0001990 | |
| GeneOntologyBiologicalProcess | regulation of blood pressure | 2.93e-04 | 237 | 51 | 5 | GO:0008217 | |
| GeneOntologyBiologicalProcess | kidney development | 3.00e-04 | 372 | 51 | 6 | GO:0001822 | |
| GeneOntologyBiologicalProcess | regulation of angiotensin levels in blood | 3.25e-04 | 11 | 51 | 2 | GO:0002002 | |
| GeneOntologyBiologicalProcess | synaptic assembly at neuromuscular junction | 3.25e-04 | 11 | 51 | 2 | GO:0051124 | |
| GeneOntologyBiologicalProcess | renal system development | 3.65e-04 | 386 | 51 | 6 | GO:0072001 | |
| GeneOntologyBiologicalProcess | regulation of heart contraction | 3.68e-04 | 249 | 51 | 5 | GO:0008016 | |
| GeneOntologyBiologicalProcess | cell activation | EPHB4 ERBB2 CD99 HLA-DQA1 KCNJ8 HLA-F CD47 SUCNR1 APP IL4I1 ITGB2 | 3.95e-04 | 1356 | 51 | 11 | GO:0001775 |
| GeneOntologyBiologicalProcess | macrophage activation | 3.97e-04 | 140 | 51 | 4 | GO:0042116 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous antigen | 3.99e-04 | 58 | 51 | 3 | GO:0019884 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | 3.99e-04 | 927 | 51 | 9 | GO:0030155 | |
| GeneOntologyBiologicalProcess | microglial cell activation | 4.20e-04 | 59 | 51 | 3 | GO:0001774 | |
| GeneOntologyBiologicalProcess | sulfur amino acid transport | 4.59e-04 | 13 | 51 | 2 | GO:0000101 | |
| GeneOntologyBiologicalProcess | proline transport | 4.59e-04 | 13 | 51 | 2 | GO:0015824 | |
| GeneOntologyBiologicalProcess | aromatic amino acid transport | 4.59e-04 | 13 | 51 | 2 | GO:0015801 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure mediated by a chemical signal | 4.63e-04 | 61 | 51 | 3 | GO:0003044 | |
| GeneOntologyBiologicalProcess | leukocyte activation involved in inflammatory response | 5.09e-04 | 63 | 51 | 3 | GO:0002269 | |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion | 5.31e-04 | 580 | 51 | 7 | GO:0022407 | |
| GeneOntologyBiologicalProcess | branched-chain amino acid transport | 5.35e-04 | 14 | 51 | 2 | GO:0015803 | |
| GeneOntologyBiologicalProcess | positive regulation of nitric oxide biosynthetic process | 5.58e-04 | 65 | 51 | 3 | GO:0045429 | |
| GeneOntologyBiologicalProcess | sulfur compound transport | 5.58e-04 | 65 | 51 | 3 | GO:0072348 | |
| GeneOntologyBiologicalProcess | regulation of type II interferon production | 5.82e-04 | 155 | 51 | 4 | GO:0032649 | |
| GeneOntologyBiologicalProcess | positive regulation of nitric oxide metabolic process | 6.10e-04 | 67 | 51 | 3 | GO:1904407 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte differentiation | 6.38e-04 | 429 | 51 | 6 | GO:1902105 | |
| GeneOntologyBiologicalProcess | leukocyte differentiation | 6.56e-04 | 789 | 51 | 8 | GO:0002521 | |
| GeneOntologyBiologicalProcess | glial cell activation | 6.94e-04 | 70 | 51 | 3 | GO:0061900 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent | 7.04e-04 | 16 | 51 | 2 | GO:0002486 | |
| GeneOntologyBiologicalProcess | regulation of cytokine production | 7.42e-04 | 1010 | 51 | 9 | GO:0001817 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte cell-cell adhesion | 7.91e-04 | 447 | 51 | 6 | GO:1903037 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway | 7.96e-04 | 17 | 51 | 2 | GO:0002484 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class Ib | 7.96e-04 | 17 | 51 | 2 | GO:0002476 | |
| GeneOntologyBiologicalProcess | type II interferon production | 8.05e-04 | 169 | 51 | 4 | GO:0032609 | |
| GeneOntologyBiologicalProcess | heart contraction | 8.30e-04 | 298 | 51 | 5 | GO:0060047 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen | 8.82e-04 | 76 | 51 | 3 | GO:0048002 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class Ib | 8.94e-04 | 18 | 51 | 2 | GO:0002428 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen via MHC class I | 8.94e-04 | 18 | 51 | 2 | GO:0042590 | |
| GeneOntologyBiologicalProcess | heart process | 9.76e-04 | 309 | 51 | 5 | GO:0003015 | |
| GeneOntologyBiologicalProcess | gap junction assembly | 9.98e-04 | 19 | 51 | 2 | GO:0016264 | |
| GeneOntologyBiologicalProcess | basic amino acid transmembrane transport | 9.98e-04 | 19 | 51 | 2 | GO:1990822 | |
| GeneOntologyBiologicalProcess | neuron projection development | KIRREL3 ERBB2 KIDINS220 HLA-B HLA-F CNTNAP2 PLPPR5 APP PTCH1 UNC5D | 1.04e-03 | 1285 | 51 | 10 | GO:0031175 |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte cell-cell adhesion | 1.09e-03 | 317 | 51 | 5 | GO:1903039 | |
| GeneOntologyBiologicalProcess | immune effector process | 1.14e-03 | 859 | 51 | 8 | GO:0002252 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 1.14e-03 | 83 | 51 | 3 | GO:0002707 | |
| GeneOntologyBiologicalProcess | myeloid leukocyte activation | 1.14e-03 | 320 | 51 | 5 | GO:0002274 | |
| GeneOntologyBiologicalProcess | import into cell | 1.15e-03 | 1074 | 51 | 9 | GO:0098657 | |
| GeneOntologyBiologicalProcess | leukocyte cell-cell adhesion | 1.22e-03 | 486 | 51 | 6 | GO:0007159 | |
| GeneOntologyBiologicalProcess | cellular extravasation | 1.22e-03 | 85 | 51 | 3 | GO:0045123 | |
| GeneOntologyBiologicalProcess | cellular response to cholesterol | 1.22e-03 | 21 | 51 | 2 | GO:0071397 | |
| GeneOntologyBiologicalProcess | regulation of amino acid transmembrane transport | 1.34e-03 | 22 | 51 | 2 | GO:1903789 | |
| GeneOntologyBiologicalProcess | regulation of amino acid import across plasma membrane | 1.34e-03 | 22 | 51 | 2 | GO:0010958 | |
| GeneOntologyBiologicalProcess | positive regulation of reactive oxygen species metabolic process | 1.39e-03 | 89 | 51 | 3 | GO:2000379 | |
| GeneOntologyBiologicalProcess | regulation of hormone levels | 1.39e-03 | 684 | 51 | 7 | GO:0010817 | |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis | 1.43e-03 | 337 | 51 | 5 | GO:0006898 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I | 1.47e-03 | 23 | 51 | 2 | GO:0019885 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | 1.49e-03 | 1115 | 51 | 9 | GO:0034220 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular extravasation | 1.60e-03 | 24 | 51 | 2 | GO:0002693 | |
| GeneOntologyBiologicalProcess | T cell activation | 1.60e-03 | 701 | 51 | 7 | GO:0042110 | |
| GeneOntologyBiologicalProcess | angiogenesis | 1.70e-03 | 708 | 51 | 7 | GO:0001525 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CNNM2 SLC13A1 MLC1 KCNJ8 TRPC1 SCN4B SLC9B2 SLC10A6 ATP2B1 ATP5F1B | 1.73e-03 | 1374 | 51 | 10 | GO:0006811 |
| GeneOntologyCellularComponent | cell surface | ACE2 HLA-B CD99 HLA-DQA1 EPHA2 HLA-F CNTNAP2 CD47 SDC3 SLC7A5 DLK1 SUCNR1 APP EPCAM ITGB2 ENPEP UNC5D ATP5F1B | 5.25e-11 | 1111 | 51 | 18 | GO:0009986 |
| GeneOntologyCellularComponent | basolateral plasma membrane | ERBB2 CNNM2 MLC1 TRPC1 SLC9B2 SLC7A5 SLC7A7 EPCAM ATP2B1 AQP7 | 4.50e-09 | 320 | 51 | 10 | GO:0016323 |
| GeneOntologyCellularComponent | basal plasma membrane | ERBB2 CNNM2 MLC1 TRPC1 SLC9B2 SLC7A5 SLC7A7 EPCAM ATP2B1 AQP7 | 1.18e-08 | 354 | 51 | 10 | GO:0009925 |
| GeneOntologyCellularComponent | apical part of cell | SLC7A9 ACE2 ERBB2 SLC13A1 MLC1 SLC9B2 SLC7A5 APP PTCH1 EPCAM ATP2B1 ENPEP | 1.38e-08 | 592 | 51 | 12 | GO:0045177 |
| GeneOntologyCellularComponent | membrane raft | 1.46e-08 | 362 | 51 | 10 | GO:0045121 | |
| GeneOntologyCellularComponent | membrane microdomain | 1.53e-08 | 364 | 51 | 10 | GO:0098857 | |
| GeneOntologyCellularComponent | basal part of cell | ERBB2 CNNM2 MLC1 TRPC1 SLC9B2 SLC7A5 SLC7A7 EPCAM ATP2B1 AQP7 | 2.19e-08 | 378 | 51 | 10 | GO:0045178 |
| GeneOntologyCellularComponent | cell projection membrane | SLC7A9 ACE2 ERBB2 EPHA2 CNTNAP2 SLC7A5 PTCH1 ATP2B1 ENPEP AQP7 | 7.51e-08 | 431 | 51 | 10 | GO:0031253 |
| GeneOntologyCellularComponent | apical plasma membrane | SLC7A9 ACE2 ERBB2 SLC13A1 MLC1 SLC9B2 SLC7A5 EPCAM ATP2B1 ENPEP | 2.33e-07 | 487 | 51 | 10 | GO:0016324 |
| GeneOntologyCellularComponent | lysosome | HLA-B MLC1 HLA-DQA1 SLC9B2 HLA-F SDC3 SLC7A5 APP IL4I1 ENPEP | 2.20e-05 | 811 | 51 | 10 | GO:0005764 |
| GeneOntologyCellularComponent | lytic vacuole | HLA-B MLC1 HLA-DQA1 SLC9B2 HLA-F SDC3 SLC7A5 APP IL4I1 ENPEP | 2.20e-05 | 811 | 51 | 10 | GO:0000323 |
| GeneOntologyCellularComponent | MHC protein complex | 3.42e-05 | 26 | 51 | 3 | GO:0042611 | |
| GeneOntologyCellularComponent | brush border membrane | 5.01e-05 | 83 | 51 | 4 | GO:0031526 | |
| GeneOntologyCellularComponent | vacuole | HLA-B MLC1 HLA-DQA1 SLC9B2 HLA-F SDC3 SLC7A5 APP IL4I1 ENPEP | 6.02e-05 | 913 | 51 | 10 | GO:0005773 |
| GeneOntologyCellularComponent | lumenal side of endoplasmic reticulum membrane | 8.47e-05 | 35 | 51 | 3 | GO:0098553 | |
| GeneOntologyCellularComponent | cell-cell junction | 8.49e-05 | 591 | 51 | 8 | GO:0005911 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 1.05e-04 | 785 | 51 | 9 | GO:0098797 | |
| GeneOntologyCellularComponent | anchoring junction | 1.05e-04 | 976 | 51 | 10 | GO:0070161 | |
| GeneOntologyCellularComponent | MHC class Ib protein complex | 1.22e-04 | 7 | 51 | 2 | GO:0032398 | |
| GeneOntologyCellularComponent | COPII-coated ER to Golgi transport vesicle | 1.50e-04 | 110 | 51 | 4 | GO:0030134 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 1.65e-04 | 212 | 51 | 5 | GO:0030666 | |
| GeneOntologyCellularComponent | recycling endosome | 2.04e-04 | 222 | 51 | 5 | GO:0055037 | |
| GeneOntologyCellularComponent | lumenal side of membrane | 2.19e-04 | 48 | 51 | 3 | GO:0098576 | |
| GeneOntologyCellularComponent | transport vesicle | 2.51e-04 | 519 | 51 | 7 | GO:0030133 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 2.51e-04 | 519 | 51 | 7 | GO:0009897 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | ACE2 ERBB2 HLA-B HLA-DQA1 SLC9B2 HLA-F CD47 PTCH1 ITGB2 ATP2B1 AQP7 | 2.56e-04 | 1307 | 51 | 11 | GO:0030659 |
| GeneOntologyCellularComponent | MHC class I protein complex | 2.59e-04 | 10 | 51 | 2 | GO:0042612 | |
| GeneOntologyCellularComponent | cation channel complex | 2.65e-04 | 235 | 51 | 5 | GO:0034703 | |
| GeneOntologyCellularComponent | vesicle membrane | ACE2 ERBB2 HLA-B HLA-DQA1 SLC9B2 HLA-F CD47 PTCH1 ITGB2 ATP2B1 AQP7 | 2.89e-04 | 1325 | 51 | 11 | GO:0012506 |
| GeneOntologyCellularComponent | presynaptic active zone | 3.88e-04 | 141 | 51 | 4 | GO:0048786 | |
| GeneOntologyCellularComponent | plasma membrane raft | 4.54e-04 | 147 | 51 | 4 | GO:0044853 | |
| GeneOntologyCellularComponent | ER to Golgi transport vesicle membrane | 5.13e-04 | 64 | 51 | 3 | GO:0012507 | |
| GeneOntologyCellularComponent | brush border | 5.15e-04 | 152 | 51 | 4 | GO:0005903 | |
| GeneOntologyCellularComponent | MHC class I peptide loading complex | 5.21e-04 | 14 | 51 | 2 | GO:0042824 | |
| GeneOntologyCellularComponent | transport vesicle membrane | 7.25e-04 | 293 | 51 | 5 | GO:0030658 | |
| GeneOntologyCellularComponent | cis-Golgi network membrane | 7.75e-04 | 17 | 51 | 2 | GO:0033106 | |
| GeneOntologyCellularComponent | membrane protein complex | ERBB2 HLA-B HLA-DQA1 KCNJ8 TRPC1 SCN4B HLA-F CNTNAP2 SLC7A5 ITGB2 ATP5F1B | 8.15e-04 | 1498 | 51 | 11 | GO:0098796 |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 9.15e-04 | 78 | 51 | 3 | GO:0048787 | |
| GeneOntologyCellularComponent | early endosome | 1.08e-03 | 481 | 51 | 6 | GO:0005769 | |
| GeneOntologyCellularComponent | side of membrane | 1.18e-03 | 875 | 51 | 8 | GO:0098552 | |
| GeneOntologyCellularComponent | presynapse | 1.27e-03 | 886 | 51 | 8 | GO:0098793 | |
| GeneOntologyCellularComponent | Golgi medial cisterna | 1.43e-03 | 23 | 51 | 2 | GO:0005797 | |
| GeneOntologyCellularComponent | astrocyte projection | 1.69e-03 | 25 | 51 | 2 | GO:0097449 | |
| GeneOntologyCellularComponent | leading edge membrane | 1.71e-03 | 210 | 51 | 4 | GO:0031256 | |
| GeneOntologyCellularComponent | coated vesicle | 1.81e-03 | 360 | 51 | 5 | GO:0030135 | |
| GeneOntologyCellularComponent | endosome | ERBB2 KIDINS220 HLA-B MLC1 HLA-DQA1 SLC9B2 HLA-F CNTNAP2 APP | 1.86e-03 | 1167 | 51 | 9 | GO:0005768 |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 2.13e-03 | 223 | 51 | 4 | GO:0098862 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 2.24e-03 | 378 | 51 | 5 | GO:0034702 | |
| GeneOntologyCellularComponent | endocytic vesicle | 2.39e-03 | 384 | 51 | 5 | GO:0030139 | |
| GeneOntologyCellularComponent | recycling endosome membrane | 2.59e-03 | 112 | 51 | 3 | GO:0055038 | |
| GeneOntologyCellularComponent | receptor complex | 2.80e-03 | 581 | 51 | 6 | GO:0043235 | |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | 4.41e-03 | 443 | 51 | 5 | GO:0098791 | |
| GeneOntologyCellularComponent | presynaptic membrane | 4.62e-03 | 277 | 51 | 4 | GO:0042734 | |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 4.72e-03 | 42 | 51 | 2 | GO:0070971 | |
| GeneOntologyCellularComponent | lysosomal membrane | 5.26e-03 | 462 | 51 | 5 | GO:0005765 | |
| GeneOntologyCellularComponent | lytic vacuole membrane | 5.26e-03 | 462 | 51 | 5 | GO:0098852 | |
| GeneOntologyCellularComponent | glial cell projection | 5.88e-03 | 47 | 51 | 2 | GO:0097386 | |
| GeneOntologyCellularComponent | synaptic vesicle | 6.12e-03 | 300 | 51 | 4 | GO:0008021 | |
| GeneOntologyCellularComponent | immunological synapse | 6.38e-03 | 49 | 51 | 2 | GO:0001772 | |
| GeneOntologyCellularComponent | cell leading edge | 7.29e-03 | 500 | 51 | 5 | GO:0031252 | |
| GeneOntologyCellularComponent | exocytic vesicle | 7.65e-03 | 320 | 51 | 4 | GO:0070382 | |
| GeneOntologyCellularComponent | vacuolar membrane | 7.72e-03 | 507 | 51 | 5 | GO:0005774 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 8.77e-03 | 523 | 51 | 5 | GO:1902495 | |
| GeneOntologyCellularComponent | secretory vesicle | 1.01e-02 | 1246 | 51 | 8 | GO:0099503 | |
| GeneOntologyCellularComponent | transporter complex | 1.07e-02 | 550 | 51 | 5 | GO:1990351 | |
| GeneOntologyCellularComponent | tertiary granule membrane | 1.37e-02 | 73 | 51 | 2 | GO:0070821 | |
| GeneOntologyCellularComponent | dendritic shaft | 1.41e-02 | 74 | 51 | 2 | GO:0043198 | |
| GeneOntologyCellularComponent | endosome membrane | 1.54e-02 | 602 | 51 | 5 | GO:0010008 | |
| GeneOntologyCellularComponent | coated vesicle membrane | 1.56e-02 | 215 | 51 | 3 | GO:0030662 | |
| HumanPheno | Odontogenic keratocysts of the jaw | 5.84e-05 | 3 | 23 | 2 | HP:0010603 | |
| HumanPheno | Cardiac fibroma | 5.84e-05 | 3 | 23 | 2 | HP:0010617 | |
| HumanPheno | Ovarian fibroma | 5.84e-05 | 3 | 23 | 2 | HP:0010618 | |
| HumanPheno | Bridged sella turcica | 5.84e-05 | 3 | 23 | 2 | HP:0005449 | |
| HumanPheno | Anterior rib cupping | 7.43e-05 | 19 | 23 | 3 | HP:0000907 | |
| HumanPheno | Plantar pits | 1.16e-04 | 4 | 23 | 2 | HP:0010612 | |
| HumanPheno | Ornithinuria | 1.16e-04 | 4 | 23 | 2 | HP:0003532 | |
| HumanPheno | Argininuria | 1.16e-04 | 4 | 23 | 2 | HP:0003268 | |
| HumanPheno | Increased glutamine family amino acid level in urine | 1.93e-04 | 5 | 23 | 2 | HP:0033093 | |
| HumanPheno | Hyperlysinuria | 1.93e-04 | 5 | 23 | 2 | HP:0003297 | |
| HumanPheno | Minor feet anomalies | 1.95e-04 | 26 | 23 | 3 | HP:0010613 | |
| HumanPheno | Abnormal feet morphology | 1.95e-04 | 26 | 23 | 3 | HP:0010611 | |
| HumanPheno | Cupped ribs | 2.72e-04 | 29 | 23 | 3 | HP:0000887 | |
| HumanPheno | Hyperfibrinogenemia | 2.89e-04 | 6 | 23 | 2 | HP:0011899 | |
| HumanPheno | Abnormal circulating lysine concentration | 4.04e-04 | 7 | 23 | 2 | HP:0010908 | |
| HumanPheno | Increased aspartate family amino acid level in urine | 4.04e-04 | 7 | 23 | 2 | HP:0033096 | |
| HumanPheno | Calcification of falx cerebri | 4.04e-04 | 7 | 23 | 2 | HP:0005462 | |
| MousePheno | urolithiasis | 2.30e-06 | 31 | 43 | 4 | MP:0005360 | |
| MousePheno | lysinuria | 2.77e-05 | 3 | 43 | 2 | MP:0020403 | |
| MousePheno | cystolithiasis | 4.01e-05 | 22 | 43 | 3 | MP:0011625 | |
| MousePheno | argininuria | 5.52e-05 | 4 | 43 | 2 | MP:0020401 | |
| MousePheno | increased lysine level | 5.52e-05 | 4 | 43 | 2 | MP:0030721 | |
| MousePheno | dermal hyperplasia | 9.19e-05 | 5 | 43 | 2 | MP:0004971 | |
| MousePheno | abnormal urinary bladder morphology | 1.01e-04 | 247 | 43 | 6 | MP:0000538 | |
| MousePheno | increased arginine level | 1.38e-04 | 6 | 43 | 2 | MP:0030664 | |
| MousePheno | abnormal lysine level | 1.92e-04 | 7 | 43 | 2 | MP:0030720 | |
| MousePheno | spinal cord inflammation | 2.56e-04 | 8 | 43 | 2 | MP:0030987 | |
| MousePheno | abnormal tail length | 3.07e-04 | 106 | 43 | 4 | MP:0011999 | |
| Domain | - | 1.32e-06 | 73 | 49 | 5 | 2.60.120.260 | |
| Domain | Galactose-bd-like | 4.64e-06 | 94 | 49 | 5 | IPR008979 | |
| Domain | AA/rel_permease1 | 4.76e-06 | 13 | 49 | 3 | IPR002293 | |
| Domain | AA_permease_2 | 4.76e-06 | 13 | 49 | 3 | PF13520 | |
| Domain | TM_rcpt_patched | 6.74e-06 | 2 | 49 | 2 | IPR004766 | |
| Domain | - | EPHB4 KIRREL3 HLA-B HLA-DQA1 EPHA2 SCN4B HLA-F CD47 UNC5D TMEM81 | 6.97e-06 | 663 | 49 | 10 | 2.60.40.10 |
| Domain | Ig-like_fold | EPHB4 KIRREL3 HLA-B HLA-DQA1 EPHA2 SCN4B HLA-F CD47 UNC5D TMEM81 | 1.21e-05 | 706 | 49 | 10 | IPR013783 |
| Domain | AA-permease/SLC12A_dom | 2.52e-05 | 22 | 49 | 3 | IPR004841 | |
| Domain | AA_permease | 2.52e-05 | 22 | 49 | 3 | PF00324 | |
| Domain | IG_LIKE | 3.77e-05 | 491 | 49 | 8 | PS50835 | |
| Domain | Ig-like_dom | 4.47e-05 | 503 | 49 | 8 | IPR007110 | |
| Domain | EGF_2 | 6.46e-05 | 265 | 49 | 6 | PS01186 | |
| Domain | MHC_I_C | 1.00e-04 | 6 | 49 | 2 | PF06623 | |
| Domain | MHC_I_a_C | 1.00e-04 | 6 | 49 | 2 | IPR010579 | |
| Domain | MHC_I/II-like_Ag-recog | 1.34e-04 | 38 | 49 | 3 | IPR011162 | |
| Domain | Ptc/Disp | 2.40e-04 | 9 | 49 | 2 | IPR003392 | |
| Domain | Patched | 2.40e-04 | 9 | 49 | 2 | PF02460 | |
| Domain | C1-set | 3.83e-04 | 54 | 49 | 3 | PF07654 | |
| Domain | IGc1 | 4.27e-04 | 56 | 49 | 3 | SM00407 | |
| Domain | Ig_C1-set | 4.73e-04 | 58 | 49 | 3 | IPR003597 | |
| Domain | Ig/MHC_CS | 4.73e-04 | 58 | 49 | 3 | IPR003006 | |
| Domain | SSD | 5.16e-04 | 13 | 49 | 2 | PS50156 | |
| Domain | SSD | 5.16e-04 | 13 | 49 | 2 | IPR000731 | |
| Domain | IG_MHC | 5.23e-04 | 60 | 49 | 3 | PS00290 | |
| Domain | EGF-like_CS | 5.92e-04 | 261 | 49 | 5 | IPR013032 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 6.01e-04 | 14 | 49 | 2 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 6.01e-04 | 14 | 49 | 2 | PS00790 | |
| Domain | EphA2_TM | 6.01e-04 | 14 | 49 | 2 | PF14575 | |
| Domain | Tyr_kinase_ephrin_rcpt | 6.01e-04 | 14 | 49 | 2 | IPR016257 | |
| Domain | Eph_TM | 6.01e-04 | 14 | 49 | 2 | IPR027936 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 6.01e-04 | 14 | 49 | 2 | IPR001090 | |
| Domain | Tyr_kinase_rcpt_V_CS | 6.01e-04 | 14 | 49 | 2 | IPR001426 | |
| Domain | EPH_LBD | 6.01e-04 | 14 | 49 | 2 | PS51550 | |
| Domain | EPH_lbd | 6.01e-04 | 14 | 49 | 2 | SM00615 | |
| Domain | Neurexin-like | 6.01e-04 | 14 | 49 | 2 | IPR003585 | |
| Domain | 4.1m | 6.01e-04 | 14 | 49 | 2 | SM00294 | |
| Domain | Ephrin_lbd | 6.01e-04 | 14 | 49 | 2 | PF01404 | |
| Domain | FA58C | 1.37e-03 | 21 | 49 | 2 | SM00231 | |
| Domain | FA58C_3 | 1.37e-03 | 21 | 49 | 2 | PS50022 | |
| Domain | MHC_I | 1.37e-03 | 21 | 49 | 2 | PF00129 | |
| Domain | MHC_I_a_a1/a2 | 1.37e-03 | 21 | 49 | 2 | IPR001039 | |
| Domain | FA58C_1 | 1.37e-03 | 21 | 49 | 2 | PS01285 | |
| Domain | FA58C_2 | 1.37e-03 | 21 | 49 | 2 | PS01286 | |
| Domain | TyrKc | 1.59e-03 | 88 | 49 | 3 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 1.59e-03 | 88 | 49 | 3 | IPR020635 | |
| Domain | F5_F8_type_C | 1.79e-03 | 24 | 49 | 2 | PF00754 | |
| Domain | FA58C | 1.79e-03 | 24 | 49 | 2 | IPR000421 | |
| Domain | - | 1.79e-03 | 24 | 49 | 2 | 3.30.500.10 | |
| Domain | MHC_I-like_Ag-recog | 1.79e-03 | 24 | 49 | 2 | IPR011161 | |
| Domain | Ephrin_rec_like | 1.95e-03 | 25 | 49 | 2 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 1.95e-03 | 25 | 49 | 2 | IPR011641 | |
| Domain | PROTEIN_KINASE_TYR | 2.10e-03 | 97 | 49 | 3 | PS00109 | |
| Domain | Tyr_kinase_AS | 2.10e-03 | 97 | 49 | 3 | IPR008266 | |
| Domain | Fibrinogen_a/b/g_C_dom | 3.18e-03 | 32 | 49 | 2 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 3.18e-03 | 32 | 49 | 2 | PS51406 | |
| Domain | FIBRINOGEN_C_1 | 3.18e-03 | 32 | 49 | 2 | PS00514 | |
| Domain | SAM/pointed | 3.58e-03 | 117 | 49 | 3 | IPR013761 | |
| Domain | EGF_1 | 4.44e-03 | 255 | 49 | 4 | PS00022 | |
| Domain | LAM_G_DOMAIN | 4.46e-03 | 38 | 49 | 2 | PS50025 | |
| Domain | Pkinase_Tyr | 4.70e-03 | 129 | 49 | 3 | PF07714 | |
| Domain | Laminin_G_2 | 4.94e-03 | 40 | 49 | 2 | PF02210 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 5.67e-03 | 138 | 49 | 3 | IPR001245 | |
| Domain | LamG | 5.95e-03 | 44 | 49 | 2 | SM00282 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 4.75e-08 | 194 | 39 | 8 | M16312 | |
| Pathway | KEGG_CELL_ADHESION_MOLECULES_CAMS | 6.79e-08 | 133 | 39 | 7 | M16476 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 2.21e-07 | 158 | 39 | 7 | MM14812 | |
| Pathway | REACTOME_HEMOSTASIS | 1.12e-05 | 679 | 39 | 10 | M8395 | |
| Pathway | REACTOME_HEMOSTASIS | 1.96e-05 | 571 | 39 | 9 | MM14472 | |
| Pathway | BIOCARTA_CTL_PATHWAY | 2.16e-05 | 20 | 39 | 3 | MM1374 | |
| Pathway | REACTOME_BASIGIN_INTERACTIONS | 3.81e-05 | 24 | 39 | 3 | MM17215 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 4.02e-05 | 70 | 39 | 4 | M12294 | |
| Pathway | REACTOME_BASIGIN_INTERACTIONS | 4.32e-05 | 25 | 39 | 3 | M4974 | |
| Pathway | WP_AXON_GUIDANCE | 4.49e-05 | 72 | 39 | 4 | M48335 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC7A9 SLC13A1 TRPC1 SLC9B2 SLC10A6 SLC7A5 SLC7A7 ATP2B1 AQP7 | 7.80e-05 | 681 | 39 | 9 | MM14985 |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 9.19e-05 | 32 | 39 | 3 | MM14957 | |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 1.01e-04 | 33 | 39 | 3 | M188 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_MIR1_2_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 1.11e-04 | 6 | 39 | 2 | M47468 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC7A9 SLC13A1 TRPC1 SLC9B2 SLC10A6 SLC7A5 SLC7A7 ATP2B1 AQP7 | 1.41e-04 | 736 | 39 | 9 | M27287 |
| Pathway | KEGG_ALLOGRAFT_REJECTION | 1.43e-04 | 37 | 39 | 3 | M18615 | |
| Pathway | REACTOME_GLI_PROTEINS_BIND_PROMOTERS_OF_HH_RESPONSIVE_GENES_TO_PROMOTE_TRANSCRIPTION | 1.55e-04 | 7 | 39 | 2 | M27501 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 1.55e-04 | 7 | 39 | 2 | M47582 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 1.55e-04 | 7 | 39 | 2 | M47530 | |
| Pathway | KEGG_GRAFT_VERSUS_HOST_DISEASE | 1.94e-04 | 41 | 39 | 3 | M13519 | |
| Pathway | KEGG_TYPE_I_DIABETES_MELLITUS | 2.24e-04 | 43 | 39 | 3 | M12617 | |
| Pathway | WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS | 2.65e-04 | 9 | 39 | 2 | M48047 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY_PTCH_CORECEPTOR | 2.65e-04 | 9 | 39 | 2 | M47893 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 2.65e-04 | 9 | 39 | 2 | MM14527 | |
| Pathway | KEGG_AUTOIMMUNE_THYROID_DISEASE | 3.94e-04 | 52 | 39 | 3 | M13103 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 4.04e-04 | 11 | 39 | 2 | M525 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 4.74e-04 | 238 | 39 | 5 | MM15076 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 4.84e-04 | 12 | 39 | 2 | M47529 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 5.82e-04 | 249 | 39 | 5 | M5988 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY | 6.65e-04 | 14 | 39 | 2 | M47414 | |
| Pathway | REACTOME_METABOLISM_OF_ANGIOTENSINOGEN_TO_ANGIOTENSINS | 7.65e-04 | 15 | 39 | 2 | MM14797 | |
| Pathway | WP_HEDGEHOG_SIGNALING_WP47 | 8.73e-04 | 16 | 39 | 2 | M39675 | |
| Pathway | KEGG_RENIN_ANGIOTENSIN_SYSTEM | 9.88e-04 | 17 | 39 | 2 | M17636 | |
| Pathway | REACTOME_METABOLISM_OF_ANGIOTENSINOGEN_TO_ANGIOTENSINS | 9.88e-04 | 17 | 39 | 2 | M27104 | |
| Pathway | REACTOME_ER_PHAGOSOME_PATHWAY | 1.11e-03 | 18 | 39 | 2 | MM14525 | |
| Pathway | REACTOME_ATTACHMENT_AND_ENTRY | 1.24e-03 | 19 | 39 | 2 | M41729 | |
| Pathway | PID_HEDGEHOG_2PATHWAY | 1.66e-03 | 22 | 39 | 2 | M211 | |
| Pathway | WP_HEDGEHOG_SIGNALING_PATHWAY | 1.66e-03 | 22 | 39 | 2 | MM15924 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 1.82e-03 | 190 | 39 | 4 | M8240 | |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 1.83e-03 | 88 | 39 | 3 | M16004 | |
| Pathway | WP_ALLOGRAFT_REJECTION | 1.89e-03 | 89 | 39 | 3 | M39398 | |
| Pathway | BIOCARTA_NKCELLS_PATHWAY | 2.15e-03 | 25 | 39 | 2 | MM1465 | |
| Pathway | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | 2.15e-03 | 25 | 39 | 2 | MM15713 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_UBIQUITINATION_OF_RTK_BY_CBL | 2.15e-03 | 25 | 39 | 2 | M47934 | |
| Pathway | REACTOME_INTERFERON_GAMMA_SIGNALING | 2.48e-03 | 98 | 39 | 3 | M965 | |
| Pathway | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | 2.89e-03 | 29 | 39 | 2 | M1062 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PTCH1_TO_HEDGEHOG_SIGNALING_PATHWAY | 2.89e-03 | 29 | 39 | 2 | M47372 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_SMO_TO_HEDGEHOG_SIGNALING_PATHWAY | 2.89e-03 | 29 | 39 | 2 | M47377 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 3.27e-03 | 108 | 39 | 3 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 3.36e-03 | 109 | 39 | 3 | MM15074 | |
| Pubmed | 1.30e-07 | 405 | 51 | 8 | 38187761 | ||
| Pubmed | 2.48e-07 | 9 | 51 | 3 | 15901826 | ||
| Pubmed | 6.47e-07 | 12 | 51 | 3 | 12134058 | ||
| Pubmed | Extensive polymorphism surrounding the murine Ia A beta chain gene. | 8.41e-07 | 13 | 51 | 3 | 6311906 | |
| Pubmed | 8.41e-07 | 13 | 51 | 3 | 9973410 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | EPHB4 ERBB2 GINM1 HLA-B EPHA2 HLA-F CD47 SLC7A5 APP ATP2B1 ATP5F1B | 1.07e-06 | 1201 | 51 | 11 | 35696571 |
| Pubmed | 1.07e-06 | 14 | 51 | 3 | 3860873 | ||
| Pubmed | 1.64e-06 | 16 | 51 | 3 | 21572416 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 19307784 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 23519058 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 30166346 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 18079969 | ||
| Pubmed | Evaluation of EphA2 and EphB4 as Targets for Image-Guided Colorectal Cancer Surgery. | 2.11e-06 | 2 | 51 | 2 | 28165374 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 34360989 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 32212383 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 27965383 | ||
| Pubmed | Phosphorylation of recombinant N-syndecan (syndecan 3) core protein. | 2.11e-06 | 2 | 51 | 2 | 9388509 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 29230040 | ||
| Pubmed | Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells. | 2.11e-06 | 2 | 51 | 2 | 32929084 | |
| Pubmed | Ptch2 loss drives myeloproliferation and myeloproliferative neoplasm progression. | 2.11e-06 | 2 | 51 | 2 | 26834157 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 18941505 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 21266456 | ||
| Pubmed | CD47 does not mediate amyloid-β(1-42) protofibril-stimulated microglial cytokine release. | 2.11e-06 | 2 | 51 | 2 | 25451248 | |
| Pubmed | Meta-Analysis of APP Expression Modulated by SARS-CoV-2 Infection via the ACE2 Receptor. | 2.11e-06 | 2 | 51 | 2 | 35163117 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 31291578 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 34990798 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 19221557 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 33436954 | ||
| Pubmed | Novel role of aminopeptidase-A in angiotensin-(1-7) metabolism post myocardial infarction. | 2.11e-06 | 2 | 51 | 2 | 24464749 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 27559086 | ||
| Pubmed | Tracts of high or low sequence divergence in the mouse major histocompatibility complex. | 2.39e-06 | 18 | 51 | 3 | 6098460 | |
| Pubmed | Genetic control of diabetogenesis in NOD/Lt mice. Development and analysis of congenic stocks. | 2.83e-06 | 19 | 51 | 3 | 2576007 | |
| Pubmed | 2.83e-06 | 19 | 51 | 3 | 18206867 | ||
| Pubmed | The ubiquitin ligase Ubr4 controls stability of podocin/MEC-2 supercomplexes. | 3.30e-06 | 69 | 51 | 4 | 26792178 | |
| Pubmed | 3.33e-06 | 20 | 51 | 3 | 12427289 | ||
| Pubmed | Nef performance in macrophages: the master orchestrator of viral persistence and spread. | 3.33e-06 | 20 | 51 | 3 | 22103834 | |
| Pubmed | Colinearity of novel genes in the class II regions of the MHC in mouse and human. | 3.88e-06 | 21 | 51 | 3 | 1855816 | |
| Pubmed | 3.88e-06 | 21 | 51 | 3 | 8084338 | ||
| Pubmed | 4.49e-06 | 22 | 51 | 3 | 28380258 | ||
| Pubmed | 5.15e-06 | 23 | 51 | 3 | 19770068 | ||
| Pubmed | Editorial. Nef: a notorious enigmatic factor in HIV biology. | 5.88e-06 | 24 | 51 | 3 | 22175768 | |
| Pubmed | Linkage map of mouse chromosome 17: localization of 27 new DNA markers. | 5.88e-06 | 24 | 51 | 3 | 2574145 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 31333001 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 25085974 | ||
| Pubmed | HLA class I and II alleles are associated with microvascular complications of type 1 diabetes. | 6.32e-06 | 3 | 51 | 2 | 23376458 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 8152808 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 35598655 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 15178563 | ||
| Pubmed | Amyloid-β inhibits No-cGMP signaling in a CD36- and CD47-dependent manner. | 6.32e-06 | 3 | 51 | 2 | 21203512 | |
| Pubmed | Ptch2, a second mouse Patched gene is co-expressed with Sonic hedgehog. | 6.32e-06 | 3 | 51 | 2 | 9462734 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 31015522 | ||
| Pubmed | Beta 2-microglobulin amyloid deposit in HLA-B27 transgenic rats. | 6.32e-06 | 3 | 51 | 2 | 17929129 | |
| Pubmed | Implications of aging and self-tolerance on the generation of immune and antitumor immune responses. | 6.32e-06 | 3 | 51 | 2 | 18593945 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 31145830 | ||
| Pubmed | Mechanism of inhibition of the tumor suppressor Patched by Sonic Hedgehog. | 6.32e-06 | 3 | 51 | 2 | 27647915 | |
| Pubmed | A role for ErbB signaling in the induction of reactive astrogliosis. | 6.32e-06 | 3 | 51 | 2 | 29238610 | |
| Pubmed | 6.68e-06 | 25 | 51 | 3 | 16091223 | ||
| Pubmed | Notch signaling is essential for ventricular chamber development. | 8.48e-06 | 27 | 51 | 3 | 17336907 | |
| Pubmed | 8.48e-06 | 27 | 51 | 3 | 12836198 | ||
| Pubmed | One protein to rule them all: modulation of cell surface receptors and molecules by HIV Nef. | 9.48e-06 | 28 | 51 | 3 | 22103833 | |
| Pubmed | 1.06e-05 | 29 | 51 | 3 | 15078178 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 14527201 | ||
| Pubmed | Human leukocyte antigens (HLA) associated with selective IgA deficiency in Iran and Sweden. | 1.26e-05 | 4 | 51 | 2 | 19052350 | |
| Pubmed | Fibroblast growth factor 10 is required for proper development of the mouse whiskers. | 1.26e-05 | 4 | 51 | 2 | 12615071 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 22585860 | ||
| Pubmed | Eph and ephrin expression in normal placental development and preeclampsia. | 1.26e-05 | 4 | 51 | 2 | 15193868 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 18007983 | ||
| Pubmed | HLA genes in Macedonians and the sub-Saharan origin of the Greeks. | 1.26e-05 | 4 | 51 | 2 | 11260506 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 19527784 | ||
| Pubmed | Morphological and phenotypical features of ovarian metastases in breast cancer patients. | 1.26e-05 | 4 | 51 | 2 | 28327103 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 11283158 | ||
| Pubmed | Overlapping and non-overlapping Ptch2 expression with Shh during mouse embryogenesis. | 1.26e-05 | 4 | 51 | 2 | 9858693 | |
| Pubmed | Association of Human Leukocyte Antigens Class I and II with Graves' Disease in Iranian Population. | 1.26e-05 | 4 | 51 | 2 | 28919585 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 33047712 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 14522093 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 9878049 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 15652424 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 9829974 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 15121303 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 15243926 | ||
| Pubmed | Amino acid transport across mammalian intestinal and renal epithelia. | 1.30e-05 | 31 | 51 | 3 | 18195088 | |
| Pubmed | 1.43e-05 | 32 | 51 | 3 | 19449444 | ||
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 1.51e-05 | 101 | 51 | 4 | 23382219 | |
| Pubmed | 1.70e-05 | 371 | 51 | 6 | 15747579 | ||
| Pubmed | Patched1 and Patched2 inhibit Smoothened non-cell autonomously. | 2.10e-05 | 5 | 51 | 2 | 27552050 | |
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 21935409 | ||
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 15323271 | ||
| Pubmed | HLA- A, B, DR and DQ alleles study in Tunisian patients with atopic dermatitis. | 2.10e-05 | 5 | 51 | 2 | 18236804 | |
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 17306585 | ||
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 34353359 | ||
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 20608062 | ||
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 18381784 | ||
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 16609350 | ||
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 20492597 | ||
| Pubmed | HLA class II and class I polymorphism in Venezuelan patients with myasthenia gravis. | 2.10e-05 | 5 | 51 | 2 | 14700596 | |
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 19159415 | ||
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 16343061 | ||
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 12753657 | ||
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 18273034 | ||
| Pubmed | HLA antigens in Greek children with allergic bronchial asthma. | 2.10e-05 | 5 | 51 | 2 | 15853903 | |
| Interaction | CAV1 interactions | EPHB4 PRPSAP1 ACE2 ERBB2 CNNM2 KIDINS220 MLC1 CD99 EPHA2 TRPC1 SLC7A5 APP PTCH1 ATP2B1 | 1.11e-09 | 724 | 49 | 14 | int:CAV1 |
| Interaction | RAB35 interactions | EPHB4 ACE2 ERBB2 KIDINS220 HLA-B CD99 EPHA2 SLC7A5 APP ATP2B1 | 9.66e-07 | 573 | 49 | 10 | int:RAB35 |
| Interaction | MRAP2 interactions | 1.19e-06 | 77 | 49 | 5 | int:MRAP2 | |
| Interaction | FGFR1 interactions | 2.33e-06 | 632 | 49 | 10 | int:FGFR1 | |
| Interaction | SSTR3 interactions | 4.37e-06 | 393 | 49 | 8 | int:SSTR3 | |
| Interaction | C11orf52 interactions | 9.60e-06 | 311 | 49 | 7 | int:C11orf52 | |
| Interaction | RAB5C interactions | 1.23e-05 | 600 | 49 | 9 | int:RAB5C | |
| Interaction | NAALADL2 interactions | 1.27e-05 | 19 | 49 | 3 | int:NAALADL2 | |
| Interaction | RND1 interactions | 2.80e-05 | 246 | 49 | 6 | int:RND1 | |
| Interaction | HLA-E interactions | 4.05e-05 | 79 | 49 | 4 | int:HLA-E | |
| Interaction | HLA-DQB1 interactions | 4.69e-05 | 82 | 49 | 4 | int:HLA-DQB1 | |
| Interaction | RND3 interactions | 5.02e-05 | 273 | 49 | 6 | int:RND3 | |
| Interaction | TMEM17 interactions | 5.13e-05 | 404 | 49 | 7 | int:TMEM17 | |
| Interaction | ST8SIA4 interactions | 5.16e-05 | 84 | 49 | 4 | int:ST8SIA4 | |
| Interaction | CXCL16 interactions | 6.47e-05 | 89 | 49 | 4 | int:CXCL16 | |
| Interaction | RHOD interactions | 6.48e-05 | 572 | 49 | 8 | int:RHOD | |
| Interaction | NTRK2 interactions | 6.70e-05 | 176 | 49 | 5 | int:NTRK2 | |
| Interaction | HLA-A interactions | 6.88e-05 | 289 | 49 | 6 | int:HLA-A | |
| Interaction | RHOC interactions | 7.50e-05 | 584 | 49 | 8 | int:RHOC | |
| Interaction | PARD3 interactions | 8.14e-05 | 298 | 49 | 6 | int:PARD3 | |
| Interaction | MGAT1 interactions | 8.37e-05 | 35 | 49 | 3 | int:MGAT1 | |
| Interaction | IHH interactions | 8.63e-05 | 6 | 49 | 2 | int:IHH | |
| Interaction | RAC3 interactions | 1.12e-04 | 619 | 49 | 8 | int:RAC3 | |
| Interaction | KDELR2 interactions | 1.19e-04 | 104 | 49 | 4 | int:KDELR2 | |
| Interaction | RHOJ interactions | 1.31e-04 | 633 | 49 | 8 | int:RHOJ | |
| Interaction | ABCA2 interactions | 1.32e-04 | 107 | 49 | 4 | int:ABCA2 | |
| Interaction | FLOT1 interactions | 1.41e-04 | 475 | 49 | 7 | int:FLOT1 | |
| Interaction | EPHA3 interactions | 1.53e-04 | 111 | 49 | 4 | int:EPHA3 | |
| Interaction | VCY interactions | 1.61e-04 | 8 | 49 | 2 | int:VCY | |
| Interaction | RYK interactions | 1.61e-04 | 212 | 49 | 5 | int:RYK | |
| Interaction | DOP1B interactions | 1.67e-04 | 44 | 49 | 3 | int:DOP1B | |
| Interaction | GPT2 interactions | 1.67e-04 | 44 | 49 | 3 | int:GPT2 | |
| Interaction | EPHA6 interactions | 1.78e-04 | 45 | 49 | 3 | int:EPHA6 | |
| Interaction | OCLN interactions | 1.93e-04 | 500 | 49 | 7 | int:OCLN | |
| Interaction | HLA-C interactions | 2.05e-04 | 353 | 49 | 6 | int:HLA-C | |
| Interaction | RHOU interactions | 2.18e-04 | 510 | 49 | 7 | int:RHOU | |
| Interaction | CRKL interactions | 2.21e-04 | 227 | 49 | 5 | int:CRKL | |
| Interaction | GLCE interactions | 2.30e-04 | 49 | 49 | 3 | int:GLCE | |
| Interaction | PAK1 interactions | 2.30e-04 | 229 | 49 | 5 | int:PAK1 | |
| Interaction | ARF5 interactions | 2.40e-04 | 231 | 49 | 5 | int:ARF5 | |
| Interaction | CABLES1 interactions | 2.44e-04 | 50 | 49 | 3 | int:CABLES1 | |
| Interaction | SH3BGRL3 interactions | 2.44e-04 | 50 | 49 | 3 | int:SH3BGRL3 | |
| Interaction | LILRB1 interactions | 2.57e-04 | 10 | 49 | 2 | int:LILRB1 | |
| Interaction | LILRB2 interactions | 2.57e-04 | 10 | 49 | 2 | int:LILRB2 | |
| Interaction | DDR1 interactions | 2.80e-04 | 130 | 49 | 4 | int:DDR1 | |
| Interaction | NTRK3 interactions | 2.80e-04 | 374 | 49 | 6 | int:NTRK3 | |
| Interaction | CRIP2 interactions | 2.90e-04 | 53 | 49 | 3 | int:CRIP2 | |
| Interaction | B3GAT1 interactions | 2.92e-04 | 377 | 49 | 6 | int:B3GAT1 | |
| Interaction | DNAJC5 interactions | 2.96e-04 | 378 | 49 | 6 | int:DNAJC5 | |
| Interaction | RHOV interactions | 3.03e-04 | 243 | 49 | 5 | int:RHOV | |
| Interaction | PDE1A interactions | 3.14e-04 | 11 | 49 | 2 | int:PDE1A | |
| Interaction | OSMR interactions | 3.24e-04 | 55 | 49 | 3 | int:OSMR | |
| Interaction | EPB41L4A interactions | 3.71e-04 | 140 | 49 | 4 | int:EPB41L4A | |
| Interaction | TM4SF1 interactions | 3.76e-04 | 12 | 49 | 2 | int:TM4SF1 | |
| Interaction | CD151 interactions | 3.99e-04 | 59 | 49 | 3 | int:CD151 | |
| Interaction | EPHA5 interactions | 4.13e-04 | 144 | 49 | 4 | int:EPHA5 | |
| Interaction | DIRAS3 interactions | 4.27e-04 | 262 | 49 | 5 | int:DIRAS3 | |
| Interaction | GRM1 interactions | 4.62e-04 | 62 | 49 | 3 | int:GRM1 | |
| Interaction | APLP1 interactions | 4.62e-04 | 62 | 49 | 3 | int:APLP1 | |
| Interaction | GJA1 interactions | 4.89e-04 | 583 | 49 | 7 | int:GJA1 | |
| Interaction | NPHS2 interactions | 5.07e-04 | 64 | 49 | 3 | int:NPHS2 | |
| Interaction | L1CAM interactions | 5.07e-04 | 64 | 49 | 3 | int:L1CAM | |
| Interaction | RHOA interactions | EPHB4 ACE2 KIDINS220 SLC13A1 HLA-B CD99 EPHA2 TRPC1 SLC7A5 ATP2B1 | 5.23e-04 | 1199 | 49 | 10 | int:RHOA |
| Interaction | PDZK1 interactions | 5.55e-04 | 66 | 49 | 3 | int:PDZK1 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.07e-05 | 394 | 36 | 7 | 471 | |
| GeneFamily | Solute carriers | 1.09e-05 | 395 | 36 | 7 | 752 | |
| GeneFamily | C1-set domain containing | 7.89e-05 | 42 | 36 | 3 | 591 | |
| GeneFamily | Histocompatibility complex|C1-set domain containing | 9.08e-05 | 44 | 36 | 3 | 588 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 3.46e-04 | 14 | 36 | 2 | 1095 | |
| GeneFamily | Immunoglobulin like domain containing | 6.60e-03 | 193 | 36 | 3 | 594 | |
| GeneFamily | Sterile alpha motif domain containing | 1.33e-02 | 88 | 36 | 2 | 760 | |
| Coexpression | ZHANG_UTERUS_C12_MONOCYTE | 7.74e-08 | 188 | 51 | 7 | MM16618 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_MESANGIAL_CELL_AGEING | 3.85e-07 | 31 | 51 | 4 | MM3729 | |
| Coexpression | JIANG_MELANOMA_TRM10_LAMINA_PROPRIA | 9.35e-07 | 91 | 51 | 5 | M48974 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_CORTEX_ARTERY_CELL_AGEING | 9.94e-07 | 39 | 51 | 4 | MM3725 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_ENDOTHELIAL_CELL_OF_LYMPHATIC_VESSEL_AGEING | 3.82e-06 | 16 | 51 | 3 | MM3766 | |
| Coexpression | TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_INTERNEURON_AGEING | 5.35e-06 | 59 | 51 | 4 | MM3688 | |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_POLYSACCHARIDE_ANTIBODY_3DY_POSITIVE | 5.72e-06 | 60 | 51 | 4 | M40971 | |
| Coexpression | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN | 6.58e-06 | 19 | 51 | 3 | MM797 | |
| Coexpression | YU_MYC_TARGETS_DN | 9.44e-06 | 68 | 51 | 4 | MM632 | |
| Coexpression | LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18_45YO_CORRELATED_WITH_ANTIBODY_RESPONSE_3DY_NEGATIVE | 1.55e-05 | 25 | 51 | 3 | M40970 | |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_DT_ANTIBODY_3DY_NEGATIVE | 1.96e-05 | 27 | 51 | 3 | M40959 | |
| Coexpression | CASTELLANO_NRAS_TARGETS_UP | 2.63e-05 | 88 | 51 | 4 | MM1087 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_B_CELL_AGEING | 2.87e-05 | 90 | 51 | 4 | MM3756 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_FENESTRATED_CELL_AGEING | 3.00e-05 | 91 | 51 | 4 | MM3720 | |
| Coexpression | ZHANG_UTERUS_C5_MACROPHAGE | 3.15e-05 | 187 | 51 | 5 | MM16611 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_PROXIMAL_CONVOLUTED_TUBULE_EPITHELIAL_CELL_AGEING | 3.95e-05 | 196 | 51 | 5 | MM3730 | |
| Coexpression | HAY_BONE_MARROW_DENDRITIC_CELL | 4.04e-05 | 197 | 51 | 5 | M39194 | |
| Coexpression | GSE22140_HEALTHY_VS_ARTHRITIC_MOUSE_CD4_TCELL_UP | 4.24e-05 | 199 | 51 | 5 | M7650 | |
| Coexpression | ZHENG_CORD_BLOOD_C9_GRANULOCYTE_MACROPHAGE_PROGENITOR | 4.34e-05 | 100 | 51 | 4 | M39218 | |
| Coexpression | FEVR_CTNNB1_TARGETS_UP | 5.08e-05 | 688 | 51 | 8 | M2342 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | 5.92e-05 | 703 | 51 | 8 | MM1055 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_HEMATOPOIETIC_PRECURSOR_CELL_AGEING | 7.24e-05 | 114 | 51 | 4 | MM3799 | |
| Coexpression | LEE_NEURAL_CREST_STEM_CELL_DN | 9.43e-05 | 122 | 51 | 4 | M10276 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_ENDOCARDIAL_CELL_AGEING | 9.93e-05 | 46 | 51 | 3 | MM3712 | |
| Coexpression | MARKEY_RB1_ACUTE_LOF_DN | 1.69e-04 | 267 | 51 | 5 | MM1091 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA1_UP | 1.74e-04 | 143 | 51 | 4 | MM1056 | |
| Coexpression | TABULA_MURIS_SENIS_TONGUE_KERATINOCYTE_AGEING | 1.79e-04 | 56 | 51 | 3 | MM3852 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_ENDOTHELIAL_CELL_AGEING | 1.83e-04 | 145 | 51 | 4 | MM3744 | |
| Coexpression | DESCARTES_FETAL_PLACENTA_MYELOID_CELLS | 1.88e-04 | 146 | 51 | 4 | M40285 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_PDC_CELL | 1.93e-04 | 147 | 51 | 4 | M45743 | |
| Coexpression | DASU_IL6_SIGNALING_UP | 2.31e-04 | 61 | 51 | 3 | M14344 | |
| Coexpression | TABULA_MURIS_SENIS_TONGUE_BASAL_CELL_OF_EPIDERMIS_AGEING | 2.55e-04 | 158 | 51 | 4 | MM3851 | |
| Coexpression | POOLA_INVASIVE_BREAST_CANCER_UP | 2.56e-04 | 292 | 51 | 5 | M5369 | |
| Coexpression | WALLACE_PROSTATE_CANCER_RACE_UP | 3.04e-04 | 303 | 51 | 5 | M10319 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | 3.32e-04 | 681 | 51 | 7 | M5314 | |
| Coexpression | MARTINEZ_TP53_TARGETS_UP | 3.72e-04 | 694 | 51 | 7 | MM1039 | |
| Coexpression | ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP | 3.84e-04 | 176 | 51 | 4 | MM1048 | |
| Coexpression | GAURNIER_PSMD4_TARGETS | 3.92e-04 | 73 | 51 | 3 | M11428 | |
| Coexpression | RODWELL_AGING_KIDNEY_UP | 4.11e-04 | 501 | 51 | 6 | M5389 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_BRUSH_CELL_AGEING | 4.25e-04 | 75 | 51 | 3 | MM3718 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_FIBROBLAST_OF_CARDIAC_TISSUE_AGEING | 4.30e-04 | 327 | 51 | 5 | MM3714 | |
| Coexpression | TABULA_MURIS_SENIS_AORTA_AORTIC_ENDOTHELIAL_CELL_AGEING | 4.42e-04 | 329 | 51 | 5 | MM3671 | |
| Coexpression | SERVITJA_ISLET_HNF1A_TARGETS_UP | 4.63e-04 | 185 | 51 | 4 | MM1072 | |
| Coexpression | GSE21063_WT_VS_NFATC1_KO_16H_ANTI_IGM_STIM_BCELL_DN | 4.92e-04 | 188 | 51 | 4 | M8252 | |
| Coexpression | BURTON_ADIPOGENESIS_8 | 5.13e-04 | 80 | 51 | 3 | M1579 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_UP | 5.33e-04 | 192 | 51 | 4 | MM752 | |
| Coexpression | SWEET_LUNG_CANCER_KRAS_UP | 5.75e-04 | 534 | 51 | 6 | MM1050 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_MESENCHYMAL_STEM_CELL_AGEING | 5.76e-04 | 196 | 51 | 4 | MM3746 | |
| Coexpression | GSE36826_WT_VS_IL1R_KO_SKIN_UP | 5.87e-04 | 197 | 51 | 4 | M9537 | |
| Coexpression | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP | 5.92e-04 | 84 | 51 | 3 | MM1049 | |
| Coexpression | GSE21927_SPLENIC_VS_TUMOR_MONOCYTES_FROM_C26GM_TUMOROUS_MICE_BALBC_DN | 5.98e-04 | 198 | 51 | 4 | M7605 | |
| Coexpression | GSE24574_BCL6_HIGH_TFH_VS_TCONV_CD4_TCELL_UP | 5.98e-04 | 198 | 51 | 4 | M8335 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_LUMINAL_EPITHELIAL_CELL_OF_MAMMARY_GLAND_AGEING | 6.01e-04 | 352 | 51 | 5 | MM3788 | |
| Coexpression | GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_CD8A_DC_UP | 6.09e-04 | 199 | 51 | 4 | M9414 | |
| Coexpression | GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_DN | 6.09e-04 | 199 | 51 | 4 | M3440 | |
| Coexpression | GSE7548_DAY7_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_DN | 6.09e-04 | 199 | 51 | 4 | M6843 | |
| Coexpression | GSE3337_CTRL_VS_4H_IFNG_IN_CD8POS_DC_UP | 6.21e-04 | 200 | 51 | 4 | M5097 | |
| Coexpression | GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP | 6.21e-04 | 200 | 51 | 4 | M7781 | |
| Coexpression | GSE7568_CTRL_VS_24H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_DN | 6.21e-04 | 200 | 51 | 4 | M364 | |
| Coexpression | GSE43957_UNTREATED_VS_NACL_TREATED_ANTI_CD3_CD28_STIM_CD4_TCELL_UP | 6.21e-04 | 200 | 51 | 4 | M9624 | |
| Coexpression | GSE1460_DP_VS_CD4_THYMOCYTE_DN | 6.21e-04 | 200 | 51 | 4 | M3454 | |
| Coexpression | GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY3_POST_IMMUNIZATION_UP | 6.21e-04 | 200 | 51 | 4 | M9278 | |
| Coexpression | GSE37301_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_RAG2_KO_NK_CELL_DN | 6.21e-04 | 200 | 51 | 4 | M8833 | |
| Coexpression | GSE19825_NAIVE_VS_DAY3_EFF_CD8_TCELL_UP | 6.21e-04 | 200 | 51 | 4 | M4305 | |
| Coexpression | MIKKELSEN_NPC_ICP_WITH_H3K27ME3 | 6.21e-04 | 19 | 51 | 2 | MM862 | |
| Coexpression | HILLION_HMGA1B_TARGETS | 6.34e-04 | 86 | 51 | 3 | M1710 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_T_CELL_AGEING | 6.40e-04 | 545 | 51 | 6 | MM3785 | |
| Coexpression | TABULA_MURIS_SENIS_BLADDER_LEUKOCYTE_AGEING | 6.90e-04 | 20 | 51 | 2 | MM3682 | |
| Coexpression | MURARO_PANCREAS_DUCTAL_CELL | 7.15e-04 | 1276 | 51 | 9 | M39173 | |
| Coexpression | SANSOM_APC_TARGETS_DN | 7.16e-04 | 366 | 51 | 5 | M1432 | |
| Coexpression | ZENG_GU_POST_ICB_METAGENE_31 | 7.32e-04 | 209 | 51 | 4 | MM17088 | |
| Coexpression | DESCARTES_FETAL_LIVER_MYELOID_CELLS | 7.45e-04 | 210 | 51 | 4 | M40229 | |
| Coexpression | FLETCHER_PBMC_BCG_10W_INFANT_PPD_STIMULATED_VS_UNSTIMULATED_10W_UP | 7.47e-04 | 91 | 51 | 3 | M41042 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_UP | 7.61e-04 | 21 | 51 | 2 | MM651 | |
| Coexpression | HAY_BONE_MARROW_NK_CELLS | 7.61e-04 | 371 | 51 | 5 | M39204 | |
| Coexpression | JACKSON_DNMT1_TARGETS_UP | 7.96e-04 | 93 | 51 | 3 | MM1185 | |
| Coexpression | BUSSLINGER_ESOPHAGEAL_DENDRITIC_CELLS | 7.99e-04 | 214 | 51 | 4 | M40005 | |
| Coexpression | BOQUEST_STEM_CELL_DN | 8.57e-04 | 218 | 51 | 4 | M1578 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_MACROPHAGE_AGEING | 8.99e-04 | 97 | 51 | 3 | MM3789 | |
| Coexpression | ZEMEK_IMMUNE_CHECKPOINT_BLOCKADE_OVARIAN_CANCER_OVERLAP_UP | 9.27e-04 | 98 | 51 | 3 | MM460 | |
| Coexpression | ZEMEK_IMMUNE_CHECKPOINT_BLOCKADE_OVARIAN_CANCER_RENCA_UP | 9.82e-04 | 100 | 51 | 3 | MM458 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_PULMONARY_INTERSTITIAL_FIBROBLAST_AGEING | 9.97e-04 | 24 | 51 | 2 | MM3773 | |
| Coexpression | AIZARANI_LIVER_C6_KUPFFER_CELLS_2 | 1.01e-03 | 228 | 51 | 4 | M39110 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | SLC7A9 ACE2 CNNM2 KIDINS220 GINM1 SLC13A1 HLA-B HLA-DQA1 TRPC1 APP SLC7A7 ENPEP | 1.90e-07 | 799 | 49 | 12 | gudmap_kidney_adult_JuxtaGlom_Ren1_1000 |
| CoexpressionAtlas | kidney_adult_RenalCortexMixed_Std_top-relative-expression-ranked_1000 | SLC7A9 ACE2 GINM1 SLC13A1 HLA-DQA1 TRPC1 CD47 SUCNR1 SLC7A7 EPCAM ENPEP AQP7 | 4.23e-07 | 861 | 49 | 12 | gudmap_kidney_adult_RenalCortexMixed_Std_1000 |
| CoexpressionAtlas | kidney_adult_RenalCortexMixed_Std_top-relative-expression-ranked_500 | 5.21e-06 | 424 | 49 | 8 | gudmap_kidney_adult_RenalCortexMixed_Std_500 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | ACE2 FREM2 CNNM2 KIDINS220 GINM1 KCNJ8 TRPC1 APP EPCAM ATP2B1 ENPEP | 5.23e-06 | 905 | 49 | 11 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 |
| CoexpressionAtlas | kidney | 8.77e-06 | 323 | 49 | 7 | kidney | |
| CoexpressionAtlas | kidney_adult_CortVasc_Tie2_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.63e-05 | 138 | 49 | 5 | gudmap_kidney_adult_CortVasc_Tie2_k4_1000 | |
| CoexpressionAtlas | kidney single cell_adult_RenalCortexMixed_StemCellamp_k-means-cluster#1_top-relative-expression-ranked_1000 | SLC7A9 ACE2 SLC13A1 HLA-B CD47 SUCNR1 APP SLC7A7 EPCAM ENPEP | 1.64e-05 | 831 | 49 | 10 | gudmap_kidney single cell_adult_RenalCortexMixed_Scamp_k1_1000 |
| CoexpressionAtlas | kidney_adult_CortVasc_Tie2_top-relative-expression-ranked_1000 | GINM1 SLC13A1 HLA-B HLA-DQA1 TRPC1 HLA-F CD47 APP SLC7A7 ENPEP | 1.91e-05 | 846 | 49 | 10 | gudmap_kidney_adult_CortVasc_Tie2_1000 |
| CoexpressionAtlas | kidney single cell_adult_RenalCortexMixed_StemCellamp_top-relative-expression-ranked_1000 | SLC7A9 ACE2 SLC13A1 HLA-B CD47 SUCNR1 APP SLC7A7 EPCAM ENPEP | 2.87e-05 | 887 | 49 | 10 | gudmap_kidney single cell_adult_RenalCortexMixed_Scamp_1000 |
| CoexpressionAtlas | gudmap_RNAseq_p2_Glomerlular Endothelial_2500_K4 | 3.05e-05 | 392 | 49 | 7 | gudmap_RNAseq_p2_Glomerlular Endothelial_2500_K4 | |
| CoexpressionAtlas | Myeloid Cells, DC.IIhilang+103-11b+.SLN, MHCIIhi CD11c+ Langerin+ CD103- CD11b+, Lymph Node, avg-3 | 4.12e-05 | 411 | 49 | 7 | GSM538271_500 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_Captopr_top-relative-expression-ranked_1000 | 6.26e-05 | 778 | 49 | 9 | gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_1000 | |
| CoexpressionAtlas | kidney_adult_RenCorpuscGlomer_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.92e-05 | 192 | 49 | 5 | gudmap_kidney_adult_RenCorpuscGlomer_k3_1000 | |
| CoexpressionAtlas | PP_GMP_top-relative-expression-ranked_100 | 8.34e-05 | 100 | 49 | 4 | PP_GMP_100 | |
| CoexpressionAtlas | kidney_adult_RenalCortexMixed_Std_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.07e-04 | 40 | 49 | 3 | gudmap_kidney_adult_RenalCortexMixed_Std_k4_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.13e-04 | 207 | 49 | 5 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000_K5 | |
| CoexpressionAtlas | kidney_adult_RenMedVasc_Tie2_top-relative-expression-ranked_1000 | 1.23e-04 | 850 | 49 | 9 | gudmap_kidney_adult_RenMedVasc_Tie2_1000 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Mesangium_2500_K1 | 1.53e-04 | 117 | 49 | 4 | gudmap_RNAseq_e15.5_Mesangium_2500_K1 | |
| CoexpressionAtlas | geo_heart_top-relative-expression-ranked_500_k-means-cluster#2 | 1.58e-04 | 118 | 49 | 4 | geo_heart_500_K2 | |
| CoexpressionAtlas | kidney_adult_Podocyte_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 1.74e-04 | 47 | 49 | 3 | gudmap_kidney_adult_Podocyte_MafB_k2_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b-.LuLN, MHCII+ CD11c+ CD8- CD11b- CD103+, Lymph Node, avg-3 | 2.18e-04 | 376 | 49 | 6 | GSM854243_500 | |
| CoexpressionAtlas | kidney single cell_adult_RenalCortexMixed_StemCellamp_k-means-cluster#4_top-relative-expression-ranked_500 | 2.76e-04 | 393 | 49 | 6 | gudmap_kidney single cell_adult_RenalCortexMixed_Scamp_k4_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.IIhilang+103+11blo.SLN, MHCIIhi CD11c+ Langerin+ CD103+ CD11b-, Lymph Node, avg-3 | 2.76e-04 | 393 | 49 | 6 | GSM538268_500 | |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_k-means-cluster#3_top-relative-expression-ranked_500 | 2.96e-04 | 139 | 49 | 4 | gudmap_kidney_adult_Mesangium_Meis_k3_500 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_top-relative-expression-ranked_500 | 3.08e-04 | 401 | 49 | 6 | gudmap_developingKidney_e11.5_ureteric bud_500 | |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.14e-04 | 258 | 49 | 5 | gudmap_kidney_adult_Mesangium_Meis_k4_1000 | |
| CoexpressionAtlas | kidney_adult_Podocyte_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.22e-04 | 142 | 49 | 4 | gudmap_kidney_adult_Podocyte_MafB_k2_1000 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_Captopr_top-relative-expression-ranked_500 | 3.29e-04 | 406 | 49 | 6 | gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b+.SLN, CD11b-FITC CD4-PE CD11c-eFluor780 CD8a-eFluor450 C, Lymph Node, avg-1 | 3.33e-04 | 407 | 49 | 6 | GSM854287_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_200 | 3.43e-04 | 59 | 49 | 3 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000 | 3.45e-04 | 976 | 49 | 9 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#3 | 3.46e-04 | 410 | 49 | 6 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K3 | |
| CoexpressionAtlas | Myeloid Cells, DC.IIhilang-103-11b+.SLN, MHCIIhi CD11c+ Langerin- CD103- CD11b+, Lymph Node, avg-3 | 3.51e-04 | 411 | 49 | 6 | GSM538274_500 | |
| CoexpressionAtlas | kidney_adult_RenMedVasc_Tie2_top-relative-expression-ranked_500 | 3.79e-04 | 417 | 49 | 6 | gudmap_kidney_adult_RenMedVasc_Tie2_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b+.SLN, CD45-APC CD11b-FITC CD11c-eFluor780 CD4-PE CD8a-eF, Lymph Node, avg-2 | 3.89e-04 | 419 | 49 | 6 | GSM854285_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_early proxim tubul_emap-28005_top-relative-expression-ranked_1000 | 3.93e-04 | 784 | 49 | 8 | gudmap_developingKidney_e15.5_early proxim tubul_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_500 | 3.99e-04 | 421 | 49 | 6 | gudmap_developingKidney_e15.5_Peripheral blastema_500 | |
| CoexpressionAtlas | Myeloid Cells, MF.169+11chi.SLN, CD11b+ CD169+ CD11chigh, Lymph Node, avg-2 | 4.77e-04 | 66 | 49 | 3 | GSM854315_100 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.42e-04 | 163 | 49 | 4 | gudmap_kidney_P0_JuxtaGlom_Ren1_k2_1000 | |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | 5.67e-04 | 450 | 49 | 6 | GSM777063_500 | |
| CoexpressionAtlas | Stromal Cells, Ep.MEChi.Th, CD45- EpCAm+ Ly51- MHCIIhi, Thymus, avg-2 | 5.67e-04 | 70 | 49 | 3 | GSM777041_100 | |
| CoexpressionAtlas | kidney_e15.5_Podocyte_MafB_top-relative-expression-ranked_200 | 6.07e-04 | 168 | 49 | 4 | gudmap_kidney_e15.5_Podocyte_MafB_200 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_500 | 6.07e-04 | 456 | 49 | 6 | gudmap_kidney_P0_JuxtaGlom_Ren1_500 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II+480lo.PC, CD115+ MHC II+ F480lo SiglecF- CD11c+, Peritoneal Cavity, avg-3 | 6.16e-04 | 72 | 49 | 3 | GSM605859_100 | |
| CoexpressionAtlas | EB blastocyst_vs_EB amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | 6.24e-04 | 300 | 49 | 5 | PCBC_ratio_EB blastocyst_vs_EB amniotic fluid MSC_cfr-2X-p05 | |
| CoexpressionAtlas | gudmap_RNAseq_p2_CD2APMEISWT_2500_K4 | 6.30e-04 | 842 | 49 | 8 | gudmap_RNAseq_p2_CD2APMEISWT_2500_K4 | |
| CoexpressionAtlas | kidney_adult_RenMedVasc_Tie2_top-relative-expression-ranked_200 | 6.63e-04 | 172 | 49 | 4 | gudmap_kidney_adult_RenMedVasc_Tie2_200 | |
| CoexpressionAtlas | gudmap_RNAseq_p2_Glomerlular Endothelial_2500_K1 | 6.70e-04 | 850 | 49 | 8 | gudmap_RNAseq_p2_Glomerlular Endothelial_2500_K1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_early proxim tubul_emap-28005_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.77e-04 | 173 | 49 | 4 | gudmap_developingKidney_e15.5_early proxim tubul_1000_k4 | |
| CoexpressionAtlas | PP_MEG_top-relative-expression-ranked_1000_k-means-cluster#3 | 6.83e-04 | 306 | 49 | 5 | PP_MEG_1000_K3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_top-relative-expression-ranked_100 | 7.21e-04 | 76 | 49 | 3 | gudmap_developingKidney_e15.5_Proximal Tubules_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_early proxim tubul_emap-28005_top-relative-expression-ranked_100 | 7.21e-04 | 76 | 49 | 3 | gudmap_developingKidney_e15.5_early proxim tubul_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.22e-04 | 176 | 49 | 4 | gudmap_developingKidney_e15.5_S-shaped body_1000_k3 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_200 | 7.38e-04 | 177 | 49 | 4 | gudmap_kidney_P0_JuxtaGlom_Ren1_200 | |
| CoexpressionAtlas | Stromal Cells, Ep.MEChi.Th, CD45-EpCAm+Ly51-MHCIIhi, Thymus, avg-1 | 7.49e-04 | 77 | 49 | 3 | GSM854302_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.II+480lo.PC, F4/80lo MHC II+ CD11c+ CD115+, Peritoneal Cavity, avg-3 | 7.49e-04 | 77 | 49 | 3 | GSM854294_100 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 8.19e-04 | 182 | 49 | 4 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_500 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II+480int.PC, CD115+ MHC II+ F480lo SiglecF- CD11c+, Peritoneal Cavity, avg-3 | 8.37e-04 | 80 | 49 | 3 | GSM605856_100 | |
| CoexpressionAtlas | kidney_adult_RenMedVasc_Tie2_k-means-cluster#3_top-relative-expression-ranked_1000 | 8.37e-04 | 80 | 49 | 3 | gudmap_kidney_adult_RenMedVasc_Tie2_k3_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500 | 8.74e-04 | 489 | 49 | 6 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_200 | 9.00e-04 | 82 | 49 | 3 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_200 | |
| CoexpressionAtlas | BM Top 100 - kidney cortex | 9.32e-04 | 83 | 49 | 3 | BM Top 100 - kidney cortex | |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_k-means-cluster#3_top-relative-expression-ranked_500 | 1.02e-03 | 193 | 49 | 4 | gudmap_developingKidney_e11.5_ureteric bud_500_k3 | |
| CoexpressionAtlas | kidney_adult_GlomCapSys_Tie2_k-means-cluster#3_top-relative-expression-ranked_500 | 1.07e-03 | 87 | 49 | 3 | gudmap_kidney_adult_GlomCapSys_Tie2_k3_500 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.08e-03 | 196 | 49 | 4 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000_K4 | |
| CoexpressionAtlas | Mesoderm Day 5_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | 1.14e-03 | 1153 | 49 | 9 | PCBC_ratio_MESO-5_vs_SC_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_k-means-cluster#4_top-relative-expression-ranked_200 | 1.18e-03 | 90 | 49 | 3 | gudmap_developingKidney_e11.5_ureteric bud_200_k4 | |
| CoexpressionAtlas | Myeloid Cells, DC.LC.Sk, MHCII+ CD11b+ CD45+, Skin, avg-2 | 1.22e-03 | 91 | 49 | 3 | GSM538280_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.11cloSer.Salm3.SI, CD45+ MHCII+ Gr1- CD11c-lo CD11b+, Small Intestine, avg-4 | 1.48e-03 | 364 | 49 | 5 | GSM854276_500 | |
| CoexpressionAtlas | kidney_adult_RenMedVasc_Tie2_k-means-cluster#4_top-relative-expression-ranked_500 | 1.51e-03 | 25 | 49 | 2 | gudmap_kidney_adult_RenMedVasc_Tie2_k4_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+.LuLN, MHCII+ CD11c+ CD8- CD11b+ CD103-, Lymph Node, avg-3 | 1.52e-03 | 366 | 49 | 5 | GSM854255_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.52e-03 | 215 | 49 | 4 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000 | 1.54e-03 | 967 | 49 | 8 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000 | 1.54e-03 | 967 | 49 | 8 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000 | 1.55e-03 | 968 | 49 | 8 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000 | |
| CoexpressionAtlas | gudmap_RNAseq_p2_CD2APMEISWT_2500_K2 | 1.55e-03 | 99 | 49 | 3 | gudmap_RNAseq_p2_CD2APMEISWT_2500_K2 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+.Salm3.SI, CD45+ MHCII+ Gr1- CD11c-hi CD11b+ CD103- F480+, Small Intestine, avg-4 | 1.55e-03 | 368 | 49 | 5 | GSM854258_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.61e-03 | 371 | 49 | 5 | Facebase_RNAseq_e9.5_Maxillary Arch_1000_K1 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C+II-.LN, F480+ Ly6c+ MHCII lo/+, Lymph Node, avg-3 | 1.67e-03 | 374 | 49 | 5 | GSM605875_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b-.Sp, CD45-APC CD11b-FITC CD11c-eFluor780 CD4-PE CD8a-eF, Spleen, avg-2 | 1.69e-03 | 375 | 49 | 5 | GSM605837_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b-.SLN, CD45-APC CD11b-FITC CD11c-eFluor780 CD4-PE CD8a-eF, Lymph Node, avg-1 | 1.71e-03 | 376 | 49 | 5 | GSM854290_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | 1.72e-03 | 984 | 49 | 8 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_200 | 1.76e-03 | 27 | 49 | 2 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_early proxim tubul_emap-28005_k-means-cluster#2_top-relative-expression-ranked_100 | 1.76e-03 | 27 | 49 | 2 | gudmap_developingKidney_e15.5_early proxim tubul_100_k2 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.79e-03 | 104 | 49 | 3 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.87e-03 | 384 | 49 | 5 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000_K3 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_top-relative-expression-ranked_500 | 1.89e-03 | 385 | 49 | 5 | gudmap_developingKidney_e14.5 whole kidney - wildtype_emap-6674_500 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_1000 | 1.94e-03 | 778 | 49 | 7 | gudmap_kidney_adult_RenalCapsule_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_top-relative-expression-ranked_1000 | 2.01e-03 | 783 | 49 | 7 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_1000 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_top-relative-expression-ranked_500 | 2.23e-03 | 400 | 49 | 5 | gudmap_kidney_adult_JuxtaGlom_Ren1_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b-.MLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-2 | 2.31e-03 | 403 | 49 | 5 | GSM605834_500 | |
| CoexpressionAtlas | Myeloid Cells, MF.RP.Sp, F4/80hi CD11blo CD11c- autofluorescent, Spleen, avg-3 | 2.31e-03 | 403 | 49 | 5 | GSM605853_500 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_dim-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.90e-09 | 187 | 51 | 7 | 0bca79cea4886b66350c56c61859bd71e1e7a85c | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_NK|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 9.40e-08 | 195 | 51 | 6 | ed41e709523cc3b86b1090d4fc0938ed47cb1fc9 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-MMP9+_Inflammatory_macrophage|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.40e-08 | 195 | 51 | 6 | 5a7c74f96f213c504abd65e751800da7e03e47d9 | |
| ToppCell | 3'-Child09-12|3' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.68e-08 | 196 | 51 | 6 | 1bcc4ffff51cdb6211824686c2422c43b09e24b2 | |
| ToppCell | 3'-Child04-06|3' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.98e-08 | 197 | 51 | 6 | 5da92d069bb32ede5e8f30c5b68c4d0790373467 | |
| ToppCell | severe-NK|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.09e-07 | 200 | 51 | 6 | 64e8a6c36e0c654b7b2416c9f19b9058215222b1 | |
| ToppCell | Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.64e-07 | 120 | 51 | 5 | e60b74758c8290919b326904ad841962256b72ec | |
| ToppCell | Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.64e-07 | 120 | 51 | 5 | 3e1ae5a5422729d484a90d72f779833fe3473fa8 | |
| ToppCell | Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.64e-07 | 120 | 51 | 5 | 24d5e86931a857bb87684392172bf04294a1a46a | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.17e-06 | 162 | 51 | 5 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Cytotoxic_CD8+_T|normal_Pleural_Fluid / Location, Cell class and cell subclass | 1.53e-06 | 171 | 51 | 5 | 6be81c20f4e962b414afcedfe478dd59c510d1e1 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.61e-06 | 173 | 51 | 5 | bba8265a58f8f5659dc7b9da2fe27b15033fce34 | |
| ToppCell | IIF-Lymphocyte-T_NK-gdT|IIF / Disease, Lineage and Cell Type | 1.86e-06 | 178 | 51 | 5 | 3344d1328fd9c570c3a4b2629edec627a442d0e0 | |
| ToppCell | ASK440-Immune-NK_cell|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.96e-06 | 180 | 51 | 5 | 340e750356d23fe9af0e8f298f8a273ff426052f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-06 | 181 | 51 | 5 | 9542c19edc9bd2cba68c01c2a8407705398e3011 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-06 | 181 | 51 | 5 | 8f04f8cac5d705dc5f6cf6f4516d6e45b0aa4ae5 | |
| ToppCell | wk_08-11-Hematologic-Myeloid-Non-cla._mono.|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.18e-06 | 184 | 51 | 5 | 324f91b70913bda3509e234aaf23b46fad91e076 | |
| ToppCell | URO-Myeloid-pDC|URO / Disease, Lineage and Cell Type | 2.18e-06 | 184 | 51 | 5 | 0edb5dd003c2bca0b9e3ec18d03610d68bd52538 | |
| ToppCell | wk_08-11-Hematologic-Myeloid-APOE+_Mac2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.24e-06 | 185 | 51 | 5 | 8f843badc0e26cb7300c83db56c7974beb90fcf3 | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMH+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.24e-06 | 185 | 51 | 5 | 097d628f92e13250c15b550f2fd1f4225fc07558 | |
| ToppCell | COVID-19_Severe-CD4+_CTL|COVID-19_Severe / Disease condition and Cell class | 2.30e-06 | 186 | 51 | 5 | 728d81405fdcd137097433dd676b26519185e916 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-06 | 186 | 51 | 5 | a417e1e21313a7e05951038cdef5ac672a9f727c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-06 | 189 | 51 | 5 | 204ab61ae606b2d9be0cb6bf6a83a011740693a8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-06 | 189 | 51 | 5 | 13fd07cc408a9486f61a7b2c3a132c52d14b438d | |
| ToppCell | Thalamus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.52e-06 | 83 | 51 | 4 | 4017af9a4804a06d0f2cd0f285ebf1b582b751de | |
| ToppCell | Thalamus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Car4_(Mural.Rgs5Acta2.Car4)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.52e-06 | 83 | 51 | 4 | 59fce941d45f9763a8584f3fd5b7c0738de9f592 | |
| ToppCell | Thalamus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Car4_(Mural.Rgs5Acta2.Car4)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.52e-06 | 83 | 51 | 4 | ebabce70dc01fdeda7fccebc2c4a0b686cda580f | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.56e-06 | 190 | 51 | 5 | 33d1b0a38267270e87702ba5794f07233acf4955 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Dendritic-pDC|bone_marrow / Manually curated celltypes from each tissue | 2.56e-06 | 190 | 51 | 5 | dde0e34f6a06cdbbb65c86472360c09f0279a572 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Dendritic|bone_marrow / Manually curated celltypes from each tissue | 2.56e-06 | 190 | 51 | 5 | 6892c603037b61ef88d6ca01b7592dc0d347d63b | |
| ToppCell | 18-Airway-Immune-Immune|Airway / Age, Tissue, Lineage and Cell class | 2.56e-06 | 190 | 51 | 5 | 09e6bbe4f1be48153dc6cd647a57a0b531b8bf99 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.56e-06 | 190 | 51 | 5 | dc20d323cee2741e39fba597263d6418ae0eadaf | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.56e-06 | 190 | 51 | 5 | ec1bd4929dc82bec2c983a31ece4e3aa82f3a2ab | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.56e-06 | 190 | 51 | 5 | ee39fb88f31d2d65b5d3e7416db68f5df07f6637 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic|lymph-node_spleen / Manually curated celltypes from each tissue | 2.62e-06 | 191 | 51 | 5 | c3ff4342e0eea1e1f071b1fbca14a6dd4df0c696 | |
| ToppCell | control-NK|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.69e-06 | 192 | 51 | 5 | cec6ab5793953072e6b0fee370551224947dd877 | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.69e-06 | 192 | 51 | 5 | 1922b0350d3375e67c314dbce8074e5cf986f2ef | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.69e-06 | 192 | 51 | 5 | 97c197643e59835c6d45dde9e549c9a1b1bb7288 | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.69e-06 | 192 | 51 | 5 | a4d161e3d48bc020e687808b352325ef9d1cc1f3 | |
| ToppCell | normal_Lymph_Node-T/NK_cells-CD8_low_T|T/NK_cells / Location, Cell class and cell subclass | 2.76e-06 | 193 | 51 | 5 | 48809047d3194aff225fc43c3d5152c20434fe62 | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.77e-06 | 85 | 51 | 4 | 7c5ea38893372fdecf7cc3ccf46a37b4ec45f0b1 | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.77e-06 | 85 | 51 | 4 | 5a2c02aeceeabd44a417b09ac8b2e2f185070b15 | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.77e-06 | 85 | 51 | 4 | 0bfabb6761a84d6a04f9fa415106a33059d78099 | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Cytotoxic_CD8+_T|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.83e-06 | 194 | 51 | 5 | 73c057b623829de793616d9d373a0018071d51d8 | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-CD8_low_T|T/NK_cells / Location, Cell class and cell subclass | 2.83e-06 | 194 | 51 | 5 | cf2480cc40f3c9be837b3934547e2ce30bd4fcd3 | |
| ToppCell | (1)_T_cells-(1)_T_CD8_activated|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.83e-06 | 194 | 51 | 5 | e3f288b58525c1f34db4459d3e83e0df695adfc7 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.83e-06 | 194 | 51 | 5 | ae5357e2a276473cde1fc8c43acaf9f69da35fd7 | |
| ToppCell | normal_Lymph_Node-T/NK_cells-Naive_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 2.83e-06 | 194 | 51 | 5 | 72749ab1dd36a0d58624328961e1db08ccba2686 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-innate_lymphocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.83e-06 | 194 | 51 | 5 | 3a0b8b5d0354c43da57bb951cd8ba878363c3de5 | |
| ToppCell | tumor_Lung-T/NK_cells-CD8_low_T|tumor_Lung / Location, Cell class and cell subclass | 2.83e-06 | 194 | 51 | 5 | 21d789585b3085aeeae3bef595c6cc5ea1c3dc4f | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.90e-06 | 195 | 51 | 5 | e1b7ef4ba2ab14d3c839b6305d91efcfd0826220 | |
| ToppCell | 3'_v3-blood-Lymphocytic_NK-NK_CD16|blood / Manually curated celltypes from each tissue | 2.90e-06 | 195 | 51 | 5 | 789149fb52d9d16393e1649358515add60d37f2d | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.90e-06 | 195 | 51 | 5 | 4a60b51f92830882872f2fe1a911db2970faf071 | |
| ToppCell | COVID-19_Severe-CD8+_Tem|COVID-19_Severe / Disease condition and Cell class | 2.90e-06 | 195 | 51 | 5 | ff7ae62393e1c858a10592db8e6d9f36b8bae396 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.90e-06 | 195 | 51 | 5 | acc603dc94ac6518adb0dffb43305b380ec75b52 | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Cytotoxic_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 2.90e-06 | 195 | 51 | 5 | bff726515ea9ce82c223e6c805000afe2e9b7206 | |
| ToppCell | severe-CD8+_Tem|severe / disease stage, cell group and cell class | 2.98e-06 | 196 | 51 | 5 | 9456a5879948e25bc483a7233c274da841ef2c68 | |
| ToppCell | distal-Hematologic-Interstitial_Macrophage-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.98e-06 | 196 | 51 | 5 | e4f40274df940e0996c555082f2bb4f99e5b0881 | |
| ToppCell | normal-na-Lymphocytic_NK-NK_dim-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.98e-06 | 196 | 51 | 5 | 61bc0d161e01f36e5bcda4d4f4693afbfe5654bb | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_dim-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.98e-06 | 196 | 51 | 5 | c25f90c4e5abfe7cfaa85bfe136c438a5179c978 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_dim|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.98e-06 | 196 | 51 | 5 | d451f279f4086fcf727af712f98923551181c76e | |
| ToppCell | normal-na-Lymphocytic_NK-NK_dim|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.98e-06 | 196 | 51 | 5 | 3360d96dc06241498995bcb875615bd4c1424f5a | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_dim-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.05e-06 | 197 | 51 | 5 | 76304df40f87224f8e415677e3ee8fb183fe0c03 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_NK-NK_dim|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.05e-06 | 197 | 51 | 5 | 4e141dfb094e10383d815fc7108b11a0584c3a4b | |
| ToppCell | normal_Lung-T/NK_cells-Cytotoxic_CD8+_T|normal_Lung / Location, Cell class and cell subclass | 3.05e-06 | 197 | 51 | 5 | b4db3bfdfc09b5fb58d70d2d5e01c71231c64ae8 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-natural_killer_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.05e-06 | 197 | 51 | 5 | 550cce374332c49893bcf4ce4b7dceb7f5fe26aa | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_NK-NK_dim-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.05e-06 | 197 | 51 | 5 | 08286770c0b707a7a4436ea8d4416ddfbfe2dc0c | |
| ToppCell | Enterocyte|World / shred on cell type and cluster | 3.05e-06 | 197 | 51 | 5 | 1dd980fd066aef21694395a4b69df938501d9631 | |
| ToppCell | background-Kupffer_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 3.05e-06 | 197 | 51 | 5 | 8b45c7ecc18d188abc8c172d9bf881c95617a46a | |
| ToppCell | BLOOD--(0)_NK_cells_(CD56dim-like)| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.05e-06 | 197 | 51 | 5 | 4c15b3386b89191af9332738e597549e2305de26 | |
| ToppCell | Healthy_donor-NK|World / disease group, cell group and cell class (v2) | 3.13e-06 | 198 | 51 | 5 | 4c9c40e91173836ad0df2eba635a4cb3385e80c6 | |
| ToppCell | (5)_Dendritic_cell-(54)_pDC|(5)_Dendritic_cell / shred on Cell_type and subtype | 3.13e-06 | 198 | 51 | 5 | fc6c6b60dddd7f2f997af0f87fae33f1c23f34a8 | |
| ToppCell | Severe-B_memory-3|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.13e-06 | 198 | 51 | 5 | a3050c126799e32f742a14396236572250476820 | |
| ToppCell | (2)_NK/T-(20)_NK_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 3.13e-06 | 198 | 51 | 5 | 2e4851e49457940e841660c5d781499ffb4a2bf1 | |
| ToppCell | (0)_NK_FCGR3Apos|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.13e-06 | 198 | 51 | 5 | 13f10f9233fc1523f0da2d9d59f3ced9c51a603a | |
| ToppCell | C_01|World / shred on cell type and cluster | 3.13e-06 | 198 | 51 | 5 | 71d38084d09a96331877384ce6346f0de4bdcef9 | |
| ToppCell | (0)_NK_cells-(0)_NK_FCGR3Apos|(0)_NK_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.13e-06 | 198 | 51 | 5 | eba39656c6f699ab297b652ded8cb9727b49593c | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-CD8_low_T|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 3.13e-06 | 198 | 51 | 5 | 8a21c183283fbc871aa729f8c42924b63018c345 | |
| ToppCell | 390C-Lymphocytic-NK_cells|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.13e-06 | 198 | 51 | 5 | 872ddb2738c5e0375830bb0e5b2c50383bf58738 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.13e-06 | 198 | 51 | 5 | 2967fb2d94662997bfe932ac299c80d6f182fb48 | |
| ToppCell | (2)_NK/T-(200)_CD56+_NK_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 3.13e-06 | 198 | 51 | 5 | 03477a6356a3c08c6e723165c0aac3464ef01667 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-mature_enterocytic|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.13e-06 | 198 | 51 | 5 | 222a060c2c63d30da34e4b71c37aa27a048d7d09 | |
| ToppCell | Healthy-NK|Healthy / disease group, cell group and cell class | 3.13e-06 | 198 | 51 | 5 | 3402f88ef2f05d61c16cbe61b996bcc8fd119261 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-natural_killer_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.13e-06 | 198 | 51 | 5 | 5607e36f393cb399fcc2504502498453fd32d96b | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.13e-06 | 198 | 51 | 5 | 6e6af8fad09f8e48b3f2ce463d5773b6a69864d1 | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-gd_T|IIF / Disease, condition lineage and cell class | 3.21e-06 | 199 | 51 | 5 | 2c0e981839c256d76fa049532c8d49f31ce9bfee | |
| ToppCell | Healthy/Control-NK|World / Disease group and Cell class | 3.21e-06 | 199 | 51 | 5 | 87af9c38938dc2db0f9cf9f3676895d2a8b5d7e6 | |
| ToppCell | Healthy/Control-NK|Healthy/Control / Disease group and Cell class | 3.21e-06 | 199 | 51 | 5 | e7fd91080fca7c31a2d48433791da3c2a4adf14d | |
| ToppCell | COVID-19_Mild-CD8+_Tem|COVID-19_Mild / Disease condition and Cell class | 3.21e-06 | 199 | 51 | 5 | 9016fbe5fe55e1ffa279ee8e8db3c93b5cf914d5 | |
| ToppCell | distal|World / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.21e-06 | 199 | 51 | 5 | 2143b31f54a1a0ec529a91b79f2cb5bb48adabcf | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.21e-06 | 199 | 51 | 5 | 01c2721bc82cd672e9477029b4a7ecc77e2f1b00 | |
| ToppCell | 11.5-Airway|11.5 / Age, Tissue, Lineage and Cell class | 3.28e-06 | 200 | 51 | 5 | 9e3a8978b76ee9ba1ccc220f128dad081eceba1a | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_other|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.28e-06 | 200 | 51 | 5 | 3cfb28299a55fc1c150262a7333c59a48ae65ad1 | |
| ToppCell | mLN-T_cell-CD8_T|T_cell / Region, Cell class and subclass | 3.28e-06 | 200 | 51 | 5 | 650916c6d2bcf00315c7a21088cb63f37bf24346 | |
| ToppCell | Bronchus_Control_(B.)-Immune-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 3.28e-06 | 200 | 51 | 5 | ad0d38ffe5ca138b40823d15b239c2f9f3f0e93c | |
| ToppCell | severe-NK|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.28e-06 | 200 | 51 | 5 | d6767f06fe13be8110a86c2a6029be2dd9ce666c | |
| ToppCell | control-NK|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.28e-06 | 200 | 51 | 5 | 3d924bb0ee84a9976de3c2e956188ade7486f8af | |
| ToppCell | Hippocampus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.64e-06 | 91 | 51 | 4 | f59908093416ca7b3ca27019d71c79acbdea18cb | |
| ToppCell | Hippocampus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.64e-06 | 91 | 51 | 4 | 104d2ab9fe5cc404388c32fafb34e421c2e138be | |
| ToppCell | Hippocampus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.64e-06 | 91 | 51 | 4 | 78e2e65beb15bf1e251974c72fbcfab817492772 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.19e-05 | 50 | 36 | 4 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPI4 | |
| Computational | Porins / transporters. | 6.35e-05 | 211 | 36 | 6 | MODULE_63 | |
| Computational | Genes in the cancer module 80. | 1.60e-04 | 32 | 36 | 3 | MODULE_80 | |
| Computational | Genes in the cancer module 51. | 2.28e-04 | 36 | 36 | 3 | MODULE_51 | |
| Computational | cell line expressed genes. | 3.52e-04 | 409 | 36 | 7 | MODULE_118 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 6.07e-04 | 50 | 36 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_17_INTERFERON_MHC_II_1 | |
| Computational | Genes in the cancer module 85. | 6.43e-04 | 51 | 36 | 3 | MODULE_85 | |
| Computational | Genes in the cancer module 293. | 7.05e-04 | 12 | 36 | 2 | MODULE_293 | |
| Computational | Genes in the cancer module 412. | 8.31e-04 | 13 | 36 | 2 | MODULE_412 | |
| Computational | Genes in the cancer module 143. | 9.68e-04 | 14 | 36 | 2 | MODULE_143 | |
| Computational | Immune (defense) response. | 1.24e-03 | 142 | 36 | 4 | MODULE_223 | |
| Computational | Genes in the cancer module 275. | 1.27e-03 | 16 | 36 | 2 | MODULE_275 | |
| Computational | Immune response. | 1.88e-03 | 398 | 36 | 6 | MODULE_75 | |
| Computational | Genes in the cancer module 186. | 2.00e-03 | 20 | 36 | 2 | MODULE_186 | |
| Drug | sodium | SLC7A9 ERBB2 SLC13A1 EPHA2 KCNJ8 TRPC1 SCN4B SLC9B2 CNTNAP2 SLC10A6 PCSK7 SLC7A5 SLC7A7 ATP2B1 | 1.24e-08 | 944 | 51 | 14 | CID000000923 |
| Drug | AC1O5VRZ | 1.26e-06 | 10 | 51 | 3 | CID006441686 | |
| Drug | amiloride | 6.24e-06 | 315 | 51 | 7 | CID000016230 | |
| Drug | N-acetylhexosamine | 9.36e-06 | 472 | 51 | 8 | CID000000899 | |
| Drug | B-46 | 2.07e-05 | 24 | 51 | 3 | CID000118445 | |
| Drug | 3-amino-4-phenylbutan-2-ol | 2.41e-05 | 75 | 51 | 4 | CID004634234 | |
| Drug | 1zp8 | 2.68e-05 | 77 | 51 | 4 | CID004369521 | |
| Drug | Asp-Lys | 2.98e-05 | 27 | 51 | 3 | CID000165361 | |
| Drug | Arg-pro-pro | 2.98e-05 | 27 | 51 | 3 | CID000152660 | |
| Drug | 2-cyanoacetamide | 3.09e-05 | 162 | 51 | 5 | CID000007898 | |
| Drug | leucine | 3.58e-05 | 167 | 51 | 5 | CID000000857 | |
| Drug | DB04683 | 4.55e-05 | 31 | 51 | 3 | CID005288113 | |
| Drug | AC1L192V | 6.59e-05 | 35 | 51 | 3 | CID000000365 | |
| Drug | potassium | KCNJ8 TRPC1 SCN4B SLC9B2 CNTNAP2 PCSK7 SLC7A5 PTCH1 SLC7A7 ATP2B1 | 6.76e-05 | 1008 | 51 | 10 | CID000000813 |
| Drug | vandetanib | 7.18e-05 | 99 | 51 | 4 | CID003081361 | |
| Drug | Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 7.29e-05 | 194 | 51 | 5 | 7322_DN | |
| Drug | B-31 | 7.34e-05 | 6 | 51 | 2 | CID000122475 | |
| Drug | 3-Aboc | 7.34e-05 | 6 | 51 | 2 | CID000124207 | |
| Drug | Clopamide [636-54-4]; Up 200; 11.6uM; PC3; HT_HG-U133A | 7.47e-05 | 195 | 51 | 5 | 6301_UP | |
| Drug | Aminopurine, 6-benzyl [1214-39-7]; Down 200; 17.8uM; PC3; HT_HG-U133A | 7.65e-05 | 196 | 51 | 5 | 3726_DN | |
| Drug | 0198306-0000 [212631-61-3]; Up 200; 10uM; PC3; HT_HG-U133A | 7.65e-05 | 196 | 51 | 5 | 7102_UP | |
| Drug | Idazoxan hydrochloride [79944-56-2]; Down 200; 16.6uM; PC3; HT_HG-U133A | 7.84e-05 | 197 | 51 | 5 | 6747_DN | |
| Drug | Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; PC3; HT_HG-U133A | 7.84e-05 | 197 | 51 | 5 | 3727_DN | |
| Drug | NSC740137 | 8.38e-05 | 103 | 51 | 4 | CID000003817 | |
| Drug | Amphotericin B [1397-89-3]; Down 200; 4.4uM; PC3; HT_HG-U133A | 8.42e-05 | 200 | 51 | 5 | 6303_DN | |
| Drug | 2-oyl | 9.03e-05 | 105 | 51 | 4 | CID000657137 | |
| Drug | Val-Val | 9.14e-05 | 39 | 51 | 3 | CID000107475 | |
| Drug | tungstate | 1.01e-04 | 108 | 51 | 4 | CID000001152 | |
| Drug | octahydroindole-2-carboxylic acid | 1.03e-04 | 7 | 51 | 2 | CID003274680 | |
| Drug | mergetpa | 1.06e-04 | 41 | 51 | 3 | CID000123726 | |
| Drug | barium chloride dihydrate | 1.23e-04 | 43 | 51 | 3 | CID000025157 | |
| Disease | Dermatitis | 2.37e-06 | 16 | 49 | 3 | C0011603 | |
| Disease | angiopoietin-1 receptor measurement | 4.09e-06 | 19 | 49 | 3 | EFO_0010600 | |
| Disease | Pigmented Basal Cell Carcinoma | 1.37e-05 | 28 | 49 | 3 | C1368275 | |
| Disease | Carcinoma, Basal Cell | 1.53e-05 | 29 | 49 | 3 | C4721806 | |
| Disease | BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 1 | 1.62e-05 | 4 | 49 | 2 | 605462 | |
| Disease | Basal cell carcinoma, susceptibility to, 1 | 1.62e-05 | 4 | 49 | 2 | cv:C2751544 | |
| Disease | Oculo-dento-digital syndrome | 1.62e-05 | 4 | 49 | 2 | C0812437 | |
| Disease | Vasodilators used in cardiac diseases use measurement | 2.48e-05 | 34 | 49 | 3 | EFO_0009926 | |
| Disease | Basal Cell Nevus Syndrome | 2.69e-05 | 5 | 49 | 2 | C0004779 | |
| Disease | Childhood Medulloblastoma | 5.07e-05 | 43 | 49 | 3 | C0278510 | |
| Disease | Melanotic medulloblastoma | 5.07e-05 | 43 | 49 | 3 | C1275668 | |
| Disease | Medullomyoblastoma | 5.07e-05 | 43 | 49 | 3 | C0205833 | |
| Disease | Desmoplastic Medulloblastoma | 5.07e-05 | 43 | 49 | 3 | C0751291 | |
| Disease | Adult Medulloblastoma | 5.07e-05 | 43 | 49 | 3 | C0278876 | |
| Disease | lymphedema, filarial elephantiasis | 5.64e-05 | 7 | 49 | 2 | EFO_0007272, MONDO_0019297 | |
| Disease | graft-versus-host disease (implicated_via_orthology) | 5.64e-05 | 7 | 49 | 2 | DOID:0081267 (implicated_via_orthology) | |
| Disease | severe acute respiratory syndrome (is_implicated_in) | 5.64e-05 | 7 | 49 | 2 | DOID:2945 (is_implicated_in) | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 7.52e-05 | 8 | 49 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | Medulloblastoma | 7.98e-05 | 50 | 49 | 3 | C0025149 | |
| Disease | human papilloma virus infection, oropharynx cancer | 9.51e-05 | 53 | 49 | 3 | EFO_0001668, EFO_1001931 | |
| Disease | dysplasia of cervix | 9.65e-05 | 9 | 49 | 2 | EFO_1000910 | |
| Disease | Glioma | 9.65e-05 | 9 | 49 | 2 | cv:C0017638 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.20e-04 | 152 | 49 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | cervical carcinoma, Cervical Intraepithelial Neoplasia Grade 2/3 | 1.21e-04 | 10 | 49 | 2 | EFO_0001061, EFO_1000166 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.45e-04 | 61 | 49 | 3 | EFO_0008317, EFO_0008596, EFO_0020946 | |
| Disease | visual epilepsy (is_implicated_in) | 1.47e-04 | 11 | 49 | 2 | DOID:11832 (is_implicated_in) | |
| Disease | Allergic Reaction | 1.59e-04 | 63 | 49 | 3 | C1527304 | |
| Disease | rheumatoid arthritis, COVID-19 | 1.67e-04 | 64 | 49 | 3 | EFO_0000685, MONDO_0100096 | |
| Disease | Hypersensitivity | 1.67e-04 | 64 | 49 | 3 | C0020517 | |
| Disease | basal cell carcinoma (is_implicated_in) | 1.76e-04 | 12 | 49 | 2 | DOID:2513 (is_implicated_in) | |
| Disease | methionine sulfone measurement | 1.76e-04 | 12 | 49 | 2 | EFO_0800072 | |
| Disease | Myasthenia gravis | 2.08e-04 | 13 | 49 | 2 | EFO_0004991 | |
| Disease | Agents acting on the renin-angiotensin system use measurement | 2.32e-04 | 335 | 49 | 5 | EFO_0009931 | |
| Disease | stomach cancer (is_implicated_in) | 2.37e-04 | 72 | 49 | 3 | DOID:10534 (is_implicated_in) | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 2.57e-04 | 74 | 49 | 3 | DOID:3748 (is_marker_for) | |
| Disease | liver neoplasm | 2.80e-04 | 15 | 49 | 2 | EFO_1001513 | |
| Disease | endoplasmic reticulum resident protein 29 measurement | 3.19e-04 | 16 | 49 | 2 | EFO_0020346 | |
| Disease | platelet-to-lymphocyte ratio | 3.35e-04 | 363 | 49 | 5 | EFO_0008446 | |
| Disease | susceptibility to shingles measurement | 3.35e-04 | 81 | 49 | 3 | EFO_0008401 | |
| Disease | response to interferon-beta, anti-drug antibody measurement | 3.62e-04 | 17 | 49 | 2 | EFO_0010559, GO_0035456 | |
| Disease | tropical spastic paraparesis | 4.06e-04 | 18 | 49 | 2 | EFO_0007527 | |
| Disease | feeling nervous measurement | 4.14e-04 | 87 | 49 | 3 | EFO_0009597 | |
| Disease | ankylosing spondylitis (is_implicated_in) | 4.54e-04 | 19 | 49 | 2 | DOID:7147 (is_implicated_in) | |
| Disease | middle cerebral artery infarction (biomarker_via_orthology) | 5.03e-04 | 93 | 49 | 3 | DOID:3525 (biomarker_via_orthology) | |
| Disease | chylomicron measurement, triglyceride measurement, very low density lipoprotein cholesterol measurement | 5.52e-04 | 96 | 49 | 3 | EFO_0004530, EFO_0008317, EFO_0008596 | |
| Disease | COVID-19 (is_implicated_in) | 5.56e-04 | 21 | 49 | 2 | DOID:0080600 (is_implicated_in) | |
| Disease | ubiquitin carboxyl-terminal hydrolase 25 measurement | 6.11e-04 | 22 | 49 | 2 | EFO_0021881 | |
| Disease | Behcet Syndrome | 7.28e-04 | 24 | 49 | 2 | C0004943 | |
| Disease | lung squamous cell carcinoma (is_implicated_in) | 7.28e-04 | 24 | 49 | 2 | DOID:3907 (is_implicated_in) | |
| Disease | anxiety measurement | 7.77e-04 | 108 | 49 | 3 | EFO_0009863 | |
| Disease | Cardiac Arrhythmia | 7.91e-04 | 25 | 49 | 2 | C0003811 | |
| Disease | treatment-resistant hypertension | 7.98e-04 | 109 | 49 | 3 | EFO_1002006 | |
| Disease | hypertension, COVID-19 | 9.23e-04 | 27 | 49 | 2 | EFO_0000537, MONDO_0100096 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 1.00e-03 | 118 | 49 | 3 | EFO_0001645, EFO_0004629 | |
| Disease | Alzheimer disease, family history of Alzheimer’s disease | 1.03e-03 | 119 | 49 | 3 | EFO_0009268, MONDO_0004975 | |
| Disease | facial morphology measurement | 1.03e-03 | 466 | 49 | 5 | EFO_0007841 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 1.08e-03 | 121 | 49 | 3 | EFO_0008595, EFO_0020943 | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 1.11e-03 | 274 | 49 | 4 | EFO_0004530, EFO_0004612 | |
| Disease | MHC class I polypeptide-related sequence B measurement | 1.14e-03 | 30 | 49 | 2 | EFO_0008234 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 1.24e-03 | 127 | 49 | 3 | EFO_0008595, EFO_0020947 | |
| Disease | seasonal allergic rhinitis | 1.30e-03 | 32 | 49 | 2 | EFO_0003956 | |
| Disease | Brain Tumor, Primary | 1.38e-03 | 33 | 49 | 2 | C0750974 | |
| Disease | Primary malignant neoplasm of brain | 1.38e-03 | 33 | 49 | 2 | C0750979 | |
| Disease | Recurrent Brain Neoplasm | 1.38e-03 | 33 | 49 | 2 | C0750977 | |
| Disease | membranous glomerulonephritis | 1.38e-03 | 33 | 49 | 2 | EFO_0004254 | |
| Disease | rheumatic heart disease | 1.38e-03 | 33 | 49 | 2 | EFO_1001161 | |
| Disease | chronic hepatitis C virus infection | 1.38e-03 | 33 | 49 | 2 | EFO_0004220 | |
| Disease | Benign neoplasm of brain, unspecified | 1.38e-03 | 33 | 49 | 2 | C0496899 | |
| Disease | Neoplasms, Intracranial | 1.38e-03 | 33 | 49 | 2 | C1527390 | |
| Disease | unipolar depression, systolic blood pressure | 1.46e-03 | 34 | 49 | 2 | EFO_0003761, EFO_0006335 | |
| Disease | reticulocyte count | 1.61e-03 | 1045 | 49 | 7 | EFO_0007986 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SAVVGILLVVVLGVV | 656 | P04626 | |
| AGVIAVIVVVVIAVV | 266 | P16422 | |
| VIVVVVIAVVAGIVV | 271 | P16422 | |
| MVGGVVIATVIVITL | 706 | P05067 | |
| VIPGIVGAVVVAVAG | 126 | P14209 | |
| GVLTSLVVLGTVGIV | 311 | P80370 | |
| VGLVGIVVGTVFIIR | 226 | P01909 | |
| IIGVTVLVVAVPEGL | 421 | P20020 | |
| GRIVAVIGAVVDVQF | 61 | P06576 | |
| ELVVFVVVGIDIGVP | 196 | Q15620 | |
| VVVGIDIGVPTVTIF | 201 | Q15620 | |
| VGIVAGLVVLGAVVT | 306 | P30511 | |
| TVLIGAVRGGHVEIV | 271 | Q9ULH0 | |
| EVIVILEGVVETTGI | 291 | Q15842 | |
| IAGTAVVGVVLVLVV | 541 | P54760 | |
| VVGITGAAVVITILK | 271 | Q9NU53 | |
| GGAVVLPLVLEVEVV | 161 | Q5SZK8 | |
| VTGRGVTVVVVDDGV | 176 | Q16549 | |
| LAAGVPVLVIIVGET | 71 | Q32ZL2 | |
| VAIIVGAIIGSGIFV | 56 | Q8MH63 | |
| VAIIVGTIIGSGIFV | 56 | Q01650 | |
| AVVGGVVAVGTVLVA | 16 | Q96BM0 | |
| TEALVIGILVVIIGV | 201 | O14520 | |
| ILCAVVVGVGLIVGL | 21 | Q07075 | |
| IVAGLAVLAVVVIGA | 311 | P01889 | |
| AVLAVVVIGAVVAAV | 316 | P01889 | |
| IAAIVGGTVAGIVLI | 701 | P05107 | |
| AVIGGVAVGVVLLLV | 536 | P29317 | |
| ISIIVGTIIGSGIFV | 36 | P82251 | |
| YLIVGVVVVVDIGVI | 1511 | Q9Y2E4 | |
| FGVVMGVIVVGIVIL | 746 | Q9BYF1 | |
| GVIVVGIVILIFTGI | 751 | Q9BYF1 | |
| VIIGVAVGAGVAFLV | 536 | Q8IZU9 | |
| ITVVGDVGGRIAIIV | 241 | Q14558 | |
| SAIIGGVIAVVIFTI | 1261 | Q9UHC6 | |
| VAGLVITVIVIVGAI | 181 | Q08722 | |
| ERKEVLVAVIVGGVV | 381 | O75056 | |
| VKAGLGVNIVGVAVV | 551 | Q9BZW2 | |
| DSAVIGGVIAVVIFI | 1236 | Q8WYK1 | |
| RVIVVGAGVAGLVAA | 61 | Q96RQ9 | |
| GVAVGITLGVVVLRN | 346 | P58872 | |
| AIPVVILVASVGIGV | 1016 | Q9Y6C5 | |
| TVTLIILAVVGGVIG | 161 | Q8IWT1 | |
| VPVVILIASVGIGVE | 1081 | Q13635 | |
| GVLEVVIGVATGSVL | 306 | Q86UD5 | |
| GLVAVVVSTIGIVIF | 341 | Q9H8M5 | |
| VVSTIGIVIFGEIVP | 346 | Q9H8M5 | |
| ALGGVVDAVGTVRVI | 681 | Q5BKX6 | |
| VGAVIVGTYNVVVVI | 621 | P48995 | |
| VRGIIVSQVSIVGVI | 66 | Q13156 | |
| IAVIVAGIVRLGQGA | 196 | Q9UM01 | |
| IGAVVGGVLLLVVAV | 196 | Q3KNW5 | |
| LGAAVVAVAVLVIGV | 386 | Q6UXZ4 | |
| GIEFVVGVLGNTIVV | 31 | Q9BXA5 | |
| GIAIGVVGGVLVRIV | 231 | Q6P7N7 | |
| VEVIAGISAVLGGII | 201 | Q15049 |